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PREFACE 
This thesis comprises six chapters where the first and last chapters are the introduction 
and conclusion, respectively. The other chapters are either published (Chapters Two, Three, 
and Four) or manuscripts submitted for publication (Chapter Five). Supplementary materials 
that are related to the work on this thesis and undertaken by the candidate have also been 
included. Ethics approval was obtained prior to commencement of the studies and, for the 
systematic review, the protocol was registered in the International Prospective Register of 
Systematic Reviews (PROSPERO). Each chapter can be read independently and contains its own 
reference list, nevertheless contributes to the whole body of work. 
Chapter One is an introduction to the thesis which provides an overview of the relevant 
literature on low back pain. The main topics evaluated include a review of the low back pain 
social and economic burden, risk factors for low back pain focusing on obesity, and causal paths 
between obesity and low back pain (e.g. genetic factors).   
Chapter Two is a systematic review conducted to investigate the relationship between obesity-
related measures (e.g. weight, body mass index) and low back pain and lumbar disc degeneration 
in twins, enabling the control for the effects of genetics and early environment. This study is 
presented as published in The Spine Journal.  
Chapter Three is a cross-sectional study conducted to investigate the relationship between 
obesity, assessed through measures that consider the magnitude and distribution of body fat 
mass, and chronic low back pain. The co-twin design was used to allow the adjustment for 
xiii 
genetics and the early environment shared by twins. Ethics approval was obtained by the Murcia 
University Ethics Committee in Spain. This study is presented as published in The European 
Spine Journal. The studies presented in Chapters Two and Three have attracted media attention 
and a lay-friendly blog post is available at the BodyInmind.org website (Appendix A).  
Chapter Four is a prospective twin cohort study conducted to investigate the role of obesity-
related measures as a risk factor for chronic and activity limiting low back pain, as well as care 
seeking due to chronic low back pain. This manuscript is presented in the format required by The 
Spine Journal where it has been accepted for publication. Additionally, an analysis of the 
concordance rates in obesity-related measures according to low back pain status in Australian 
twins is presented as supplementary findings at the end of this chapter.  
Chapter Five is an observational study, including both cross-sectional and longitudinal data, 
conducted to investigate the relationship between diabetes type 2 and back pain [including lower 
back pain, neck pain, and spinal pain (concurrent lower back and neck pain)]. A co-twin design 
was used to account for the influence of genetics and early shared environment. Ethics approval 
was obtained by the Murcia University Ethics Committee. This manuscript is presented in the 
format required by PLOS ONE where it is under review. 
Lastly, Chapter Six consists of an overview of the main findings of the thesis, discusses the 
clinical implications, and proposes directions for future research.   
xiv 
ABSTRACT  
Low back pain is a well-recognized worldwide health problem due to its high prevalence 
and substantial economic impact. Despite abundant research on risk factors for low back pain, 
the pathoanatomical cause in the majority of cases remains unknown and is commonly termed 
nonspecific low back pain. The lack of knowledge regarding risk factors for low back pain is 
likely to be a critical reason for the limited progress in identifying effective management and 
preventative strategies. Identifying factors associated with the onset of low back pain is crucial in 
the field, because of its direct implications for the design of effective evidence-based 
preventative approaches.   
A large number of risk factors for low back pain have been proposed. One of the 
plausible modifiable risk factors, obesity, has been commonly investigated, given that it could be 
a potential target for preventative interventions. Despite a considerable number of published 
studies exploring the relationship between obesity and back pain, the nature of the relationship 
remains unclear. As both obesity and low back pain cluster in families with evidence suggesting 
moderate to high heritability (phenotypic variance attributable to genetic variance) of these traits, 
it is possible that the conflicting findings regarding a direct link between obesity and low back 
pain arise from limitations in previous studies such as the lack of adjustment for familial factors 
(e.g. genetics). 
To overcome this gap in the literature and contribute to a better understanding of the 
effect of obesity on low back pain, this thesis reports a series of studies designed to evaluate 
whether obesity is a risk factor for low back pain in twins. The twin methodology is an excellent 
resource for studying the significance of genetics as identical twins [monozygotic (MZ)] and 
fraternal twins [dizygotic (DZ)] share approximately 100% and 50% of their genes, respectively. 
xv 
The environment and gene-environment interaction are also taken into account because twin 
pairs tend to be exposed to a common environment until early adulthood. As a result, studying 
the relationship between obesity and low back pain in twins who are discordant for low back 
pain status, allows the control for genetic and early environmental influences on this relationship. 
Theoretically, this method (case-control co-twin design) permits a more robust examination of 
obesity as a risk for low back pain, rather than being merely an associated factor. 
The first study of this thesis, presented in Chapter Two, is a systematic review with 
meta-analysis that investigated the relationship between obesity-related measures (e.g. weight, 
body mass index) and low back pain, or lumbar disc degeneration, in twins. The use of twin 
studies allows the comparison of the estimates with and without adjustment for familial 
influences. A comprehensive search was conducted of five international databases, identifying 
11 eligible twin studies that were included in this review. Due to the heterogeneity of the 
included studies, pooling the data for a meta-analysis was only possible for low back pain but not 
for disc degeneration. Findings from the unpaired analyses, when familial factors were not taken 
into account, suggested a consistent, but weak (odds ratios < 2) association between obesity and 
both low back pain and lumbar disc degeneration. Importantly, the magnitude of the estimates 
diminished, and did not remain significant, for the most well-adjusted models in which only MZ 
twins were included. These findings suggested that genetics and early environment shared by 
twins potentially confound the association between obesity and low back pain or lumbar disc 
degeneration.  
Apart from the evidence of familial confounding, our systematic review revealed 
limitations in previous studies investigating the association between obesity and low back pain, 
such as the use of imprecise measures to define obesity (e.g. body mass index), and a lack of 
xvi 
longitudinal twin studies. To adress these gaps in the literature, two studies were conducted, 
presented as Chapters Three and Four in this thesis. Using cross-sectional and longitudinal data 
from the Murcia Twin Registry, Spain, obesity measures that consider the magnitude and 
distribution of body fat mass were used to investigate the association between obesity and 
chronic low back pain in twins. 
In both Chapters Three and Four, general obesity was assessed by both body mass 
index and percentage of fat mass (measured by bioimpedance), while abdominal obesity was 
evaluated through waist circumference and waist-hip ratios. All obesity measures were classified 
into four categories (quartiles) according to percentile distributions of the data (e.g. category one 
≤ 25th lowest percentile). Chronic low back was the primary outcome. Sequential multivariate 
logistic regression models were used to investigate the association between obesity-related 
measures and chronic low back pain outcomes. In the first phase, also referred to as total sample 
analysis, twins were analysed independently (unpaired); and, therefore, the within-pair 
concordance for low back pain status was not taken into account. In the subsequent analytical 
steps, only complete twin pairs discordant for chronic low back pain (e.g. one twin reported low 
back pain whereas the co-twin did not) were included in the multivariate conditional logistic 
regression models, including all DZ and MZ pairs, followed by analysis of DZ pairs only, and 
then followed by analysis of MZ pairs only. Theoretically, the levels of adjustment for 
confounding factors such as genetics and early environment shared by twins increase throughout 
the analytical phases. 
Our findings from the cross-sectional analysis (Chapter Three), which included 1128 
female Spanish twins, revealed that lifetime prevalence of chronic low back pain was weakly 
associated [odds ratio (OR) < 2] with general obesity (body mass index = OR 1.13; 95% CI 1.02 
xvii 
to 1.26; percent body fat = OR 1.15, 95% CI 1.01 to 1.32) in the least adjusted models (total 
sample analyses). Nevertheless, after the full adjustment for genetics and early shared 
environmental factors in MZ twins dissimilar for low back pain status, the association did not 
persist. Consistent with the findings from the systematic review presented in Chapter Two, our 
results from the cross-sectional analysis indicated that obesity is unlikely to be directly, and 
independently, linked to chronic low back pain.  
Similarly, the results from the longitudinal analysis presented in Chapter Four 
demonstrated no temporal effect of obesity on low back pain outcomes. For this longitudinal 
study, 1,098 twins who were free of chronic low back pain at baseline were included. After two 
to four years, no increase in the risk for the development chronic low back pain, activity-limiting 
low back pain, or care-seeking for low back pain due to obesity-related measures was observed.  
A final exploration of the possible link between obesity and low back pain is presented as 
a supplementary analysis including intrapair correlations between obesity-related measures, 
according to low back pain status in 31 pairs of Australian MZ twins. The obesity-related 
measures investigated were the same as those investigated in Chapters Three and Four: body 
mass index, percent fat mass, waist circumference, and waist-hip ratio. For this analysis, low 
back pain was defined as pain in the lower back in the previous month. As suspected, due to the 
known moderate heritability of low back pain, the majority of twin pairs (24 pairs, 77.4%) were 
concordant for both having (12 pairs, 38.7%) and for not having (12 pairs, 38.7%) low back pain 
in the previous month. Only seven pairs (22.6%) reported being discordant for low back pain. 
Similarly, an excellent agreement for obesity-related measures was found within MZ twin pairs, 
with most intraclass correlation coefficients being greater than 0.8. Interestingly, the results of 
this analysis showed that the intrapair difference in obesity-related measures was not higher in 
xviii 
discordant twin pairs than in concordant pairs for low back pain status. Moreover, for the 
discordant pairs, the findings indicated that those twins with low back pain were not heavier than 
their co-twins. Consequently, these findings provide additional support for the lack of a direct 
link between obesity-related measures and LBP. 
Obesity is a chronic metabolic condition associated with metabolically driven systemic 
inflammation, which is involved in the development of insulin resistance and type 2 diabetes. 
Systemic inflammation has been suggested as a possible trigger for the link between obesity, 
type 2 diabetes and chronic pain. For example, it has been shown that obese people with elevated 
inflammatory markers (e.g. C-reactive protein) are almost three times more likely to report low 
back pain than those with normal levels. Hence, the final study of this thesis (Chapter Five) 
aimed to investigate the relationship between chronic back pain and type 2 diabetes. Cross-
sectional and longitudinal analyses were conducted to explore the bi-directional association 
between type 2 diabetes and chronic back pain [any or severe (≥ 9) low back pain, neck pain, or 
both]. Due to the well-recognised genetic influence on type 2 diabetes and back pain, the co-twin 
case-control design was used to adjust for familial confounders following the sequential analyses 
mentioned earlier. The sample investigated was from the Murcia Twin Registry, composed of 
2,096 twins in the cross-sectional analysis and 1,098 twins in the longitudinal analysis. Type 2 
diabetes was associated with the prevalence of chronic low back pain, neck pain, and both. The 
association was stronger for severe cases of back pain (i.e. severe chronic spinal pain: OR 
adjusted for age and sex = 3.33; 95% 1.47 to 7.53). No association was found in the cross-
sectional case-control co-twin and the longitudinal analyses. Although our results suggest a 
positive association, based on the cross sectional total sample analysis, between type 2 diabetes 
xix 
and chronic back pain, these conditions are unlikely to be directly linked, and instead, are likely 
to coexist due to common genetic or environmental factors in their pathogenesis. 
In summary, the studies conducted as part of this thesis have provided an important 
contribution to a better understanding of suspected risk factors for low back pain such as obesity 
and type 2 diabetes.  Based on the findings, a direct causal link between these risk factors and 
low back pain is questionable. Firstly, in the cross-sectional analyses, the magnitude of 
significant associations was mostly weak (OR < 2). When high levels of control for important 
confounding factors such as genetics was applied, these associations did not remain significant. 
In twin pairs discordant for low back pain status, no between-twin difference was observed in 
obesity-related measures. Lastly, obesity and type 2 diabetes do not seem to precede chronic low 
back pain as no temporal effect was observed. Consequently, our studies indicated that obesity 
and type 2 diabetes coexist with the presence of low back pain possibly due to common genetic 
or environmental influences on their pathogenesis. In light of the new evidence, novel study 
directions have been proposed in regards to innovative preventative and management approaches 
for low back pain. 
Keywords: Low back pain, Risk Factors, Obesity, Body mass index, Twins  
xx 
CHAPTER ONE 
Introduction 
1
INTRODUCTION 
1.1 Definition and epidemiology of low back pain  
 Low back pain (LBP) is an extremely common health problem [1, 2]. It is usually defined 
as activity-limiting pain that occurs in the lower back, including any region from the lower 
gluteal folds to the lower margin of the twelfth ribs [3]. LBP is not a life-threatening condition. 
However, it represents one of the biggest challenges for the public health system because it is 
commonly associated with disability and substantial healthcare costs [2, 4]. Despite extensive 
research dedicated to understanding risk factors for LBP, the majority of LBP is still considered 
nonspecific in nature, due to the current lack of identified pathoanatomical causes of symptoms. 
The uncertainty regarding risk factors or identifiable causes of LBP may explain why current 
prevention and management strategies fail to yield substantial effects [3]. 
 Approximately 40% of the global population experience at least one episode of LBP 
during their lifetime [5]. Pain recurrence is frequent, and roughly two-thirds of people with 
recent onset of chronic LBP (i.e. symptoms lasting longer than three months) will not recover 
within a year [6]. All age groups seem to be affected by LBP, and its prevalence does not 
substantially differ across the lifespan [7]. For example, the point prevalence of LBP in adults is 
approximately 11.9 %, while in children and adolescents it is 12.0% [5, 8]. However, severe and 
persistent cases of LBP, which have a greater impact on disability and healthcare expenditure, 
are more common in older people. Regardless of age, LBP seems to be more prevalent among 
females than males [5].  
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1.2 The impact of low back pain on individuals and society 
 LBP is a major public health problem worldwide, owing largely to high healthcare 
utilisation and sick leave rates [2, 4, 5, 9-11]. In the last 20 years, LBP was the main contributor 
to the global disease burden in terms of years lived with disability (YLDs). Between 1990 and 
2013, the YLDs due to LBP has increased by 57% [95% Confidence Interval (CI): 54 to 62%], 
and continues to rise [11]. LBP is also the fourth most burdensome disease, out of 315 health 
conditions, regarding disability-adjusted life years (DALYs). DALYs are another measure 
commonly used to quantify the overall disease burden, considering time lost due to ill-health, 
disability or premature mortality [12].  
 The economic burden attributed to LBP has been abundantly documented in the literature 
and is described in terms of direct, indirect, and/or total costs (i.e. including direct and indirect 
costs) [4, 13]. Direct costs refer to monetary exchange for healthcare services (e.g. medications, 
hospital services, imaging), while indirect costs refer to expenses resulting from LBP, such as 
work absences and productivity losses [13, 14]. Although differences in study methodologies 
have generated a wide range of cost outcomes related to the burden of LBP, the magnitude of the 
economic impact is evident nonetheless [13]. For example, the estimated total cost in Australia is 
AU$ 9.17 billion per annum, while in the United Kingdom it is ₤12.33 billion [10, 15], and in the 
United States direct costs alone are estimated at $90.6 billion per year [16]. 
Despite the strong evidence that LBP is highly prevalent, disabling and costly, it seems 
that the burden of LBP remains largely unrecognised by policymakers due to little policy 
discussion of the options available to address LBP prevention [11, 17]. In recent years, in an 
attempt to mitigate the global burden of LBP, a shift in healthcare towards prevention of LBP 
3
and related disability has been recommended to policymakers [11, 15, 17-19]. As a result, 
improving understanding of risk factors for LBP is now a recognised health priority [12, 17, 20]. 
1.3 Risk factors for low back pain 
 A risk factor is defined as a factor that plays a determinant role in the etiology of a health 
condition (e.g. LBP) [21]. Risk factors for LBP have become the subject of much research over 
recent decades, as identification of these factors could provide a rationale for establishing more 
effective preventative and management strategies. More than 100 potentially modifiable (e.g. 
obesity) and non-modifiable (e.g. age, sex) risk factors for LBP have been suggested, although 
the precise mechanisms responsible for the onset of LBP are still poorly understood [20, 22-30]. 
Risk factors that have been extensively investigated include those related to lifestyle (e.g. 
obesity, smoking), socioeconomic status (e.g. income), genetics, pathoanatomical changes (e.g. 
disc degeneration), psychological factors (e.g. depression), and the demands of an occupation 
(e.g. heavy physical work,) [20, 26, 27, 30-33]. In particular, focusing on potentially modifiable 
risk factors for LBP, such as obesity, is crucial for the development of evidence-based 
preventative strategies [34]. 
 In this thesis, a series of studies has been conducted to explore whether obesity-related 
factors increase the risk of developing LBP. If obesity is confirmed as a determinant factor for 
LBP, preventative strategies targeting weight control could contribute to clinical outcome 
improvements on a public health level, resulting in substantial economic benefits. There are 
many successful examples in the literature of preventative approaches that have provided 
noteworthy benefits to public health by reducing the incidence of diseases (e.g. hypertension, 
cardiovascular diseases, and type 2 diabetes) [35-38]. For example, obesity is a risk factor for 
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chronic diseases such as type 2 diabetes and cardiovascular diseases [39]. Randomised clinical 
trials for type 2 diabetes have demonstrated that lifestyle-focused interventions, such as weight 
control, decreased body weight and plasma glucose, and have resulted in long-term protection 
against type 2 diabetes [40-42]. Consequently, the maintenance of healthy weight is relevant and 
recommended in current guidelines for the prevention of type 2 diabetes [43, 44]. Due to the 
inconclusive evidence concerning whether obesity is a true risk factor for LBP, the European 
Guideline for LBP prevention has stated that there is currently no evidence for or against 
recommending weight control as a preventative action to reduce LBP or its related disability 
[45].  
1.4 Obesity and low back pain  
 Obesity is deﬁned as an excessive fat accumulation that presents a risk to one’s health 
[46]. As the number of obese people has dramatically increased globally, obesity has become a 
major public health epidemic [47-49]. The most common method adopted worldwide to assess 
obesity is body mass index (BMI). BMI estimates obesity by dividing body weight (kilograms) 
by height (meters) squared. According to the World Health Organization, those with a BMI 
higher than 30.0 kg/m2 are classified as obese [50]. Obesity has been associated with a wide 
range of disabling and/or life-threatening health conditions, such as type 2 diabetes, 
cardiovascular diseases, some cancers, and musculoskeletal pain [30, 51-55]. For several of these 
health conditions (e.g. type 2 diabetes, cancer), obesity is well established as a risk factor [54]. In 
contrast, the nature of the link between obesity and LBP remains unknown. 
 The causal relationship between obesity and LBP may be intuitive, on account of the 
cumulative increased mechanical demands on the spine [56]. To maintain a healthy spine, 
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mechanical load is necessary as it assists with the transportation of nutrients and applies a direct 
and indirect stimulus to the intervertebral discs [57]. Being overweight or obese could induce 
spine degeneration, due to prolonged, accumulated day-to-day hyper-physiological loading 
which could lead to osteoarthritis and chronic pain [56]. Nonetheless, the current evidence 
suggests that the simplistic hypothesis of mechanical overload on the spine may not be valid 
[56]. Other mechanisms explaining the obesity-LBP relationship warrant exploration, as obesity 
is a known risk factor for pain and osteoarthritis in non-weight-bearing joints (e.g hand) [56]. 
Moreover, ethno-geographic factors strongly influence the relationship between obesity and 
LBP, as this relationship is not consistent across countries [58]. Currently, over 100 studies 
(including reviews) have been published, and the evidence of a direct link between obesity and 
LBP remains inconclusive [30, 59, 60].  
 The controversial epidemiologic evidence of the link between obesity and LBP can be 
attributed largely to the high number of studies with poor methodological quality. First, the data 
used to investigate the association between obesity and LBP have been derived mostly from 
cross-sectional studies [30]. Second, only a few prospective cohort studies have been published, 
and some of these studies may be affected by attrition bias [30]. Third, confounding factors 
potentially affecting the obesity-LBP relationship have often not been, or only partially, 
accounted for [30, 61]. Lastly, the most common anthropometric measure used to define obesity, 
BMI, has known limitations and can be inaccurate in quantifying obesity [62, 63].  
1.4.1 Factors influencing the obesity- low back pain relationship   
A significant obstacle in ascertaining whether obesity is a risk factor for LBP is, 
undoubtedly, the need for considering potential confounders that may be implicated in obesity, 
6
LBP, or both. Evidence suggests that the obesity-LBP relationship is affected by a large number 
of factors, including age, sex, body fat distribution, low-grade systemic inflammation, physical 
activity, emotional disorder, smoking, education, environmental, cultural, and genetic factors [2, 
64-67]. For example, one study showed that obesity, indicated by higher BMI and larger waist 
circumferences, was associated with chronic LBP in males and females. However, these 
associations did not remain significant after adjusting for age, smoking, and educational levels in 
males. In contrast, in the adjusted analysis for females, the magnitude of the association 
increased between obesity measures and chronic LBP [68]. Levels of physical activity have also 
been shown to influence the association between obesity and LBP [65]. Obese sedentary 
individuals are at a greater risk of suffering LBP compared to those who are obese but physically 
active. There is also evidence of a biopsychosocial interaction between emotional disorders, 
obesity, and LBP, as the association between LBP and obesity-related measures is stronger in 
individuals with symptoms of depression and anxiety [64].  
It is likely that the complex relationship between obesity and LBP also involves genetic 
and familial factors [33, 69-72]. It has been shown that the association between obesity measures 
and LBP does not remain significant after controlling for genetic and environmental factors 
shared by twins [69, 70]. Several studies have consistently reported a substantial genetic 
contribution to both LBP and obesity, as well as to other variables that could affect obesity, LBP, 
or both (e.g. physical activity, depression, eating disorders) [32, 33, 71, 73-77]. For example, 
eating disorders aggregate in families (heritability of 57%; 95% CI 30 to 77%) [78]. Illness 
behaviour, including how people communicate symptoms and cope with pain, may also be 
passed on by family members [79]. Moreover, demographic and lifestyle factors shared by 
family members, such as the intake of complex carbohydrates and alcohol, educational 
7
achievements, and exercise habits may all influence the development of health conditions such 
obesity and LBP [80]. Thus, genetic and environmental factors shared by families may be 
important contributors in the aetiology and maintenance of LBP, obesity, or both. However, 
genetic and familial factors have rarely been adjusted for as potential confounders when 
investigating the obesity-LBP relationship [32, 33, 81, 82].  
Environmentally determined differences (e.g. variation in socioeconomic status, diet) and 
the genetic background of populations also appear to influence the obesity-LBP relationship. 
Evidence from a study that used cross-sectional data from nine countries found that the 
association between obesity and LBP varies substantially across countries [58]. Whilst in some 
countries the association is strong [e.g. Russia: Odds ratio (OR) 2.76; 95% CI 1.83 to 4.17), in 
other countries, the association is weak (Poland: OR 1.47; 95% CI 1.10 to 1.96) or absent (e.g. 
China: OR 1.08; 95% CI 0.87 to 1.34) [58]. This difference may be attributed to not only 
environmental (e.g. geographic location, cultural influences) or genetic differences, but also to 
gene-environmental interactions [83]. Growing evidence suggests that genetic susceptibility to 
chronic health conditions may be, at least, partially dependent upon environmental influences 
[82, 84]. A simple example is the rapid increase in obesity prevalence in recent decades being the 
result of environmental and cultural influences rather than genetic factors [85]. Environmental 
exposures such as diet and physical activity, which are often driven by family habits, can induce 
persistent alterations in genes - a phenomenon known as epigenetics [80, 86-89]. Epigenetic 
processes, such as DNA methylation, appear to play an important role in the development of 
chronic health conditions [90-93]. Thus, it is likely that genes act differently in the presence of 
certain environmental factors, thereby influencing the obesity-LBP relationship. 
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To gain a clearer understanding as to whether obesity is a strong risk factor for LBP, it is 
plausible to use a study design that allows for the control of genetic and shared environmental 
factors. The twin design is a unique and powerful alternative for the study of risk factors for 
complex health conditions such as LBP [94]. Using twins in research has an additional important 
advantage over traditional methods because genetic and early shared environmental factors are 
accounted for as potential factors that influence the association between obesity and LBP. 
Consequently, the twin design allows for more precise estimates of risks for LBP, which are 
currently lacking. This thesis enriches the LBP field by exploring the relationship between 
obesity-related risk factors for chronic LBP in adult twins, accounting for the effect of genetic 
and environmental influences.  
1.4.1.1 The twin design 
Genetic and environmental mechanisms underlying the development of obesity and LBP 
are supported by overwhelming evidence [71, 77, 82, 95, 96]. Importantly, gene-environment 
interactions are also likely to be a source of variation for these complex phenotypes [58, 83]. 
Twin studies, in particular when a within-pair twin case-control design is employed, represent a 
unique method to overcome the nature-nurture dilemma when investigating the obesity-LBP 
relationship. Studying twin pairs discordant for a health condition (e.g. one twin reports LBP, 
whereas the co-twin do not) is regarded as an experimental opportunity, as it allows the most 
efficient match for both genetic and environmental influences as well as gene-environmental 
interactions in early life [97, 98]. The twin method is based on the fact that identical twins 
[monozygotic (MZ)] and fraternal twins [dizygotic (DZ)] share approximately 100% and 50% of 
their genes, respectively. Analysing twin pairs also parses environmental influences on a trait or 
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disease, as twins tend to be exposed to a common environment until early adulthood (e.g. diet, 
education, and parents socio-economic status) [98, 99]. Theoretically, greater control for 
potential confounders in twin pair analyses, allows for more precise estimates of the magnitude 
of association between obesity-related risk factors and LBP and, in turn, provides an opportunity 
to understand whether obesity is a true risk factor for LBP.  
This thesis focusses on twin studies, particularly the use of the within-pair twin case-
control design. First, Chapter Two presents a systematic review with meta-analysis aimed at 
critically evaluating the literature on obesity-related measures (e.g. weight, BMI) as risk factors 
for LBP, or lumbar disc degeneration, in twins. For the first time, the comparison of the 
estimates for the obesity-LBP association was performed when genetics and familial influences 
are, or are not, adjusted for. In Chapters Three, Four, and Five, obesity-related risk factors 
(including general obesity, abdominal obesity, and type 2 diabetes) for LBP are investigated 
using a within-pair twin case-control design. The twin studies presented in this thesis are 
primarily made up of cross-sectional and longitudinal data from the Murcia Twin Registry in 
Spain.  
 
1.4.2 Limitations in the assessment of obesity  
In addition to the lack of adjustment for important confounders, a major limitation in 
many studies investigating obesity as a risk factor for LBP is the use of BMI as the sole measure 
to classify obesity [30]. BMI, an index based on height and weight, is a crude measure that 
estimates body fatness [50]. While BMI is very commonly used in clinical settings and research 
contexts worldwide, several reports have cautioned against its use because of serious 
methodological flaws [63, 100, 101].  
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One of the deficiencies of using BMI as a measure of obesity is its crude estimation of fat 
mass without distinguishing adipose tissue from other body components such as muscle and 
bone [63, 100-102]. As genetic backgrounds (i.e. genotypic base of a population) influence body 
composition, a given BMI value does not necessarily correspond to the same degree of adiposity 
in different ethnic populations [103]. Furthermore, although body composition changes across 
the lifespan, BMI does not take age into consideration [62]. As a result, the standard BMI cut-off 
values may not be valid to identify obesity across different ages and ethnicities [101, 103]. For 
these reasons, BMI has poor sensitivity and specificity in classifying obesity [62]. For example,  
41% of men and 32% of women were misclassified as obese when BMI was used, compared to 
the ‘gold standard’ method of assessing body fat percentages, dual-energy x-ray absorptiometry 
[104]. Another factor rendering impression to the results of previous studies is that self-reported 
data (height and weight) are frequently used to calculate BMI [62]. Self-reported values tend to 
result in underestimation of weight and overestimation of height [105]. These limitations of BMI 
as a measure of obesity may lead to misclassification of fatness, potentially over- or under-
estimating the prevalence of obesity [62, 63, 102-104]. Therefore, the use of BMI as a sole 
measure to define obesity may introduce bias to studies that have investigated the effects of 
obesity on LBP and may, in turn, provide imprecise estimates of the link between obesity and 
LBP.   
Another limitation when using BMI to assess obesity is that the distribution of fat mass in 
the body is not taken into account. Several studies in adults have suggested that greater 
abdominal adiposity (greater fat mass around the waist) presents a higher health risk than overall 
adiposity [106-109]. Due to the large variation in body fat distribution within a narrow range of 
BMI, abdominal obesity can differ substantially across populations [103]. Preliminary evidence 
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suggests that body fat distribution influences the association between obesity and LBP [68, 110, 
111]. Rather than the amount of body fat, abdominal obesity appears to have a stronger 
association with LBP [66, 110]. Consequently, additional anthropometric measures that consider 
not only the total amount, but also the distribution, of body fat should be used to reach valid 
conclusions on the effects of obesity on LBP [102].  
To overcome the limitations in the previous research, the studies presented in this thesis 
(Chapters Three and Four) explored the association between obesity-related measures and LBP 
in twins using measures that consider the magnitude of fatness as well as body fat distribution. 
To investigate general obesity, in addition to BMI, the percentage of fat mass was investigated. 
Percentage of fat mass was measured by bioelectrical impedance which is a valid, non-invasive 
method [112]. This method uses a small electric current that passes through the body to calculate 
the impedance of both extracellular and intracellular fluids to estimate the amount of fat and lean 
mass separately [113]. Other measures of fatness related to abdominal obesity (excess intra-
abdominal fat), like waist circumference and waist-to-hip ratio, were also investigated in this 
thesis. Waist circumference has been proposed as one of the most appropriate measures to 
estimate risk to health, as it predicts the risk for several health conditions (e.g. cardiovascular 
diseases, diabetes) [106]. Furthermore, waist-to-hip ratio has also been used as an obesity-risk 
estimator, as it has a highly significant association with a number of health conditions (e.g., 
cardiovascular disease) [109, 114]. To further investigate if obesity measures are strong 
determinates for LBP, a Supplementary Analysis is presented in Chapter Four comparing the 
concordance of these four obesity measures (BMI, percentage of fat mass, waist circumference, 
and waist-to-hip ratio) in identical twins dissimilar for LBP status.  
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1.4.3 Obesity, type 2 diabetes, and low-grade systemic inflammation   
Obesity, in particular abdominal obesity, is associated with metabolically driven systemic 
inflammation which is involved in the pathogenesis of obesity-related insulin resistance and type 
2 diabetes [115]. A number of studies have suggested that systemic inflammation possibly 
explains the link between obesity, type 2 diabetes, and chronic pain [115-117]. It has been shown 
that obese people with elevated systemic inflammation (e.g. C-reactive protein) are almost three 
times more likely to report LBP than those with normal levels [118]. Furthermore, people with 
type 2 diabetes, who have well-recognised low-grade systemic inflammation, are twice as likely 
to report LBP [119]. Importantly, it has been suggested that having both diabetes and LBP result 
in a greater impact on people’s health and the complexity of healthcare required [120, 121]. 
Therefore, the final study of this thesis (Chapter Five) explored the relationship between 
another obesity-related health risk factor, “type 2 diabetes”, and chronic back pain 
(including LBP, neck pain, or both) in twins. As previously mentioned, the within-pair twin case-
control design accounts for the possible influence of familial factors in these relationships [71, 
122, 123]. The presence of genetic component underlying the variation (heritability) of these 
conditions is well established [heritability of LBP (52%; 95% CI 33 to 72%), neck pain (48%; 
95% CI 29 to 67%), and type 2 diabetes (72%; 95% CI 61 to 78%)] [71, 122]. 
 
1.5 Aims of this thesis  
The aims of this thesis were to: 
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1. Systematically review the literature on twin studies to investigate the strength of the
relationship between obesity-related measures and LBP, or lumbar disc degeneration; and to
determine whether genetics and the early environment influence these associations.
2. Investigate the strength of the association between obesity and chronic LBP when obesity is
assessed in terms of the total amount as well as the distribution of body fat; and accounting 
for genetic and early shared environmental factors.  
3. Examine whether obesity-related measures increase the risk of developing chronic LBP using
longitudinal data accounting for genetic and early shared environmental factors.
4. Investigate whether the intra-pair differences in obesity-related measures are higher in twin
pairs discordant for LBP than in pairs concordant for LBP.
5. Explore the potential bi-directional relationship between type 2 diabetes and chronic back
pain (including chronic LBP, chronic neck pain, or both) in twins.
14
1.6 References 
1. Itz C, et al., Clinical course of non-specific low back pain: A systematic review of
prospective cohort studies set in primary care. European Journal of Pain, 2013. 17(1): p.
5-15.
2. Balagué F, et al., Non-specific low back pain. The Lancet, 2012. 379(9814): p. 482-491.
3. Dionne C, et al., A consensus approach toward the standardization of back pain
definitions for use in prevalence studies. The Spine Journal, 2008. 33(1): p. 95-103.
4. Gore M, et al., The burden of chronic low back pain: Clinical comorbidities, treatment
patterns, and health care costs in usual care settings. The Spine Journal, 2012. 37(11): p.
668-677.
5. Hoy D, et al., A systematic review of the global prevalence of low back pain. Arthritis &
Rheumatism, 2012. 64(6): p. 2028-2037.
6. Costa L, et al., Prognosis for patients with chronic low back pain: Inception cohort study.
The British Medical Journal, 2009. 339: p. 3829.
7. Dunn K, et al., Cassidy, Low back pain across the life course. Best practice & research
Clinical rheumatology, 2013. 27(5): p. 591-600.
8. Calvo-Muñoz I, et al., Prevalence of low back pain in children and adolescents: A meta-
analysis. BioMed Central Pediatrics, 2013. 13(1): p. 1.
9. Manchikanti L, et al., Epidemiology of low back pain in adults. Neuromodulation:
Technology at the Neural Interface, 2014. 17: p. 3-10.
10. Maniadakis N, et al.,  The economic burden of back pain in the UK. Pain, 2000. 84(1): p.
95-103.
15
11. Vos T, et al.,  Global, regional, and national incidence, prevalence, and years lived with
disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A
systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 2015.
386(9995): p. 743-800.
12. Kassebaum N, et al., Global, regional, and national disability-adjusted life-years
(DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990 -
2013;2015: A systematic analysis for the Global Burden of Disease Study. The Lancet,
2015. 388(10053): p. 1603-1658.
13. Dagenais S, et al., A systematic review of low back pain cost of illness studies in the
United States and internationally. The Spine Journal, 2008. 8(1): p. 8-20.
14. Goetzel R, et al., The health and productivity cost burden of the “top 10” physical and
mental health conditions affecting six large US employers in 1999. Journal of
Occupational and Environmental Medicine, 2003. 45(1): p. 5-14.
15. Walker B, et al.,  Grant, Low back pain in australian adults: The economic burden. Asia
Pacific Journal of Public Health, 2003. 15(2): p. 79-87.
16. Luo X, et al., Estimates and patterns of direct health care expenditures among
individuals with back pain in the United States. Spine, 2004. 29(1): p. 79-86.
17. Buchbinder R, et al., Placing the global burden of low back pain in context. Best Practice
& Research Clinical Rheumatology, 2013. 27(5): p. 575-589.
18. Hoy D, et al., Reflecting on the global burden of musculoskeletal conditions: Lessons
learnt from the global burden of disease 2010 study and the next steps forward. Annals of
the Rheumatic Diseases, 2015. 74(1): p. 4-7.
16
19. Hoy D, et al., The global burden of low back pain: Estimates from the Global Burden of 
Disease 2010 study. Annals of the Rheumatic Diseases, 2014: p. 2013-204428.
20. Bakker E, et al., Spinal mechanical load as a risk factor for low back pain: A systematic
review of prospective cohort studies. Spine, 2009. 34(8): p. 281-293.
21. Kraemer H, et al., How do risk factors work together? Mediators, moderators, and 
independent, overlapping, and proxy risk factors. American Journal of Psychiatry, 2001. 
158(6): p. 848-856.
22. Hancock M, et al. Risk factors for a recurrence of low back pain. The Spine Journal,
2015. 15(11): p. 2360-2368.
23. Frymoyer J, et al., Risk factors in low-back pain. An epidemiological survey. The Journal 
of Bone and Joint Surgery, 1983. 65(2): p. 213-218.
24. Heliövaara M, Risk factors for low back pain and sciatica. Annals of Medicine, 1989. 
21(4): p. 257-264.
25. Valat J, et al., Low back pain: Risk factors for chronicity. Revue du Rhumatisme 
(English ed.), 1997. 64(3): p. 189-194.
26. Balague F, et al., Non-specific low back pain in children and adolescents: Risk factors.
European Spine Journal, 1999. 8(6): p. 429-438.
27. Feldman D, et al., Smoking: a risk factor for development of low back pain in
adolescents. Spine, 1999. 24(23): p. 2492.
28. Linton S, A review of psychological risk factors in back and neck pain. Spine, 2000.
25(9): p. 1148-1156.
29. Kerr M, et al., Biomechanical and psychosocial risk factors for low back pain at work.
American Journal of Public Health, 2001. 91(7): p. 1069.
17
30. Shiri R, et al., The association between obesity and low back pain: A meta-analysis.
American Journal of Epidemiology, 2010. 171(2): p. 135-154.
31. Pinheiro M, et al., Genetics and the environment affect the relationship between
depression and low back pain: A co-twin control study of Spanish twins. Pain, 2015.
156(3): p. 496-503.
32. Ferreira P, et al., Nature or nurture in low back pain? Results of a systematic review of
studies based on twin samples. European Journal of pain, 2013. 17(7): p. 957-71.
33. Livshits G, et al., Lumbar disc degeneration and genetic factors are the main risk factors
for low back pain in women: The UK Twin Spine Study. Annals of the Rheumatic
Diseases, 2011. 70(10): p. 1740-1745.
34. Brady S, et al., Predictors of back pain in middle aged women: Data from the australian 
longitudinal study on women's health. Arthritis Care Research (Hoboken), 2016.
35. Centers for Disease Control and Prevention. Ten great public health achievements 
worldwide, 2001-2010. Morbidity and Mortality Weekly Report, 2011. 60(24): p. 814-818.
36. Centers for Disease Control and Prevention. Ten great public health achievements: 
United States, 1900-1999. Morbidity and Mortality Weekly Report, 1999. 48(12): p. 241-
243. 
37. Whelton P, et al., Primary prevention of hypertension: Clinical and public health
advisory from The National High Blood Pressure Education Program. Journal of the
American Medical Association, 2002. 288(15): p. 1882-1888.
38. Ratner R, et al., An update on the diabetes prevention program. Endocrine Practice,
2006. 12(Supplement 1): p. 20-24.
18
39. Guh D, et al., The incidence of co-morbidities related to obesity and overweight: A
systematic review and meta-analysis. BioMed Central Public Health, 2009. 9(88): p. 1-
20.
40. Lindstrom J, et al., Improved lifestyle and decreased diabetes risk over 13 years: Long-
term follow-up of the randomised Finnish Diabetes Prevention Study (DPS).
Diabetologia, 2013. 56(2): p. 284-293.
41. Li G, et al., The long-term effect of lifestyle interventions to prevent diabetes in the China
Da Qing Diabetes Prevention Study: A 20-year follow-up study. The Lancet, 2008.
371(9626): p. 1783-1789.
42. Knowler W, et al., 10-year follow-up of diabetes incidence and weight loss in the
Diabetes Prevention Program Outcomes Study. The Lancet, 2009. 374(9702): p. 1677-
1686. 
43. Dyson P, et al., Diabetes UK evidence-based nutrition guidelines for the prevention and
management of diabetes. Diabetic Medicine, 2011. 28(11): p. 1282-1288.
44. World Health Organization. Guidelines for the prevention, management and care of
diabetes mellitus. 2006.
45. Burton A, et al., Chapter 2: European guidelinesfor prevention in low back pain.
European Spine Journal, 2006. 15(2): p. 136-168.
46. World Health Organization. Obesity: Preventing and managing the global epidemic. N
894. World Health Organization, 2000. 894: p 1-253.
47. Ogden, et al., Carroll, Prevalence of overweight, obesity, and extreme obesity among
adults: United States, trends 1960-1962 through 2007-2008. National Center for Health
Statistics, 2010. 6(1): p. 1-6.
19
48. De Onis M, et al., Global prevalence and trends of overweight and obesity among
preschool children. The American Journal of Clinical Nutrition, 2010. 92(5): p. 1257-
1264. 
49. Flegal K, et al., Prevalence and trends in obesity among US adults, 1999-2000. Journal
of the American Medical Association, 2002. 288(14): p. 1723-1727.
50. World Health Organization. Obesity and overweight: World Health Organization global
strategy on diet, physical activity and health. Geneva: WHO (2008).
51. Bener A, et al., Obesity and low back pain. Collegium Antropologicum, 2003. 27(1): 
p. 95-104.
52. Fierabracci P, et al., Obesity-related comorbidities, in minimally invasive bariatric and 
metabolic surgery. 2015, Springer. p. 25-34.
53. Hubert H, et al., Obesity as an independent risk factor for cardiovascular disease: A 26-
year follow-up of participants in the Framingham Heart Study. Circulation, 1983. 67(5):
p. 968-977.
54. De Pergola G, et al., Obesity as a major risk factor for cancer. Journal of Obesity, 2013.
2013. 
55. Vucenik I, et al., Obesity and cancer risk: Evidence, mechanisms, and recommendations.
Annals of the New York Academy of Sciences, 2012. 1271(1): p. 37-43.
56. Cicuttini F, et al., Not just loading and age: The dynamics of osteoarthritis, obesity and
inflammation. The Medical Journal of Australia, 2016. 204(2): p. 47.
57. Chan S, et al.,  The effects of dynamic loading on the intervertebral disc. The European
Spine Journal, 2011. 20(11): p. 1796-1812.
20
58. Koyanagi A, et al., The association between obesity and back pain in nine countries: A
cross-sectional study. BioMed Central Public Health, 2015. 15(1): p. 1.
59. Garzillo M, et al.,  Does obesity cause low back pain? Journal of Manipulative and
Physiological Therapeutics, 1993. 17(9): p. 601-604.
60. Mirtz T, et al., Greene, Is obesity a risk factor for low back pain? An example of using the
evidence to answer a clinical question. Chiropractic & Osteopathy, 2005. 13(1): p. 1.
61. Hegmann K, et al., Causal associations and determination of work-relatedness. Guides to
the Evaluation of Disease and Injury Causation, 2008: p. 33-46.
62. Rothman K, BMI-related errors in the measurement of obesity. International Journal of
Obesity, 2008. 32: p. 56-59.
63. Burkhauser R, et al., Beyond BMI: The value of more accurate measures of fatness and
obesity in social science research. Journal of Health Economics, 2008. 27(2): p. 519-529.
64. Chou L, et al., The association between obesity and low back pain and disability is
affected by mood disorders: A population-based, cross-sectional study of men.
Medicine (Baltimore), 2016. 95(15): p. 3367.
65. Shiri R, et al. The role of obesity and physical activity in non-specific and radiating low
back pain: The Young Finns Study. Seminars in Arthritis and Rheumatism (Elsevier). 42
(6) 2013.
66. Shiri R, et al., The association between obesity and the prevalence of low back pain in
young adults the cardiovascular risk in Young Finns Study. American Journal of
Epidemiology, 2008. 167(9): p. 1110-1119.
21
67. Shiri R, et al., The association between obesity and the prevalence of low back pain in 
young adults the cardiovascular risk in Young Finns Study. American Journal of 
Epidemiology, 2008. 167(9): p. 1110-1119.
68. Han T, et al., The prevalence of low back pain and associations with body fatness, fat
distribution and height. International Journal of Obesity, 1997. 21(7): p. 600-607.
69. Hestbaek L, et al., Are lifestyle-factors in adolescence predictors for adult low back
pain? A cross-sectional and prospective study of young twins. BioMed Central
Musculoskeletal Disorders, 2006. 15 (7): p. 7.
70. Leboeuf-Yde C, et al., Low back pain and lifestyle. Part II--Obesity. Information from a
population-based sample of 29,424 twin subjects. Spine, 1999. 24(8): p. 779-783.
71. MacGregor A, et al., Structural, psychological, and genetic influences on low back and
neck pain: A study of adult female twins. Arthritis Care & Research, 2004. 51(2): p. 160-
167. 
72. Wright L, et al., Chronic pain, overweight, and obesity: Findings from a community-
based twin registry. Journal of Pain, 2010. 11(7): p. 628-635.
73. Sullivan P, et al., Kendler, Genetic epidemiology of major depression: review and meta-
analysis. The American Journal of Psychiatry, 2000. 157(10): p. 1552-62.
74. Reichborn-Kjennerud T, et al., Back-neck pain and symptoms of anxiety and depression:
A population-based twin study. Psychological Medicine, 2002. 32(6): p. 1009-1020.
75. Mustelin L, et al., Genetic influences on physical activity in young adults: A twin study.
Medicine & Science in Sports & Exercise, 2012. 44(7): p. 1293-1301.
76. Locke A, et al., Genetic studies of body mass index yield new insights for obesity biology.
Nature, 2015. 518(7538): p. 197-206.
22
77. Marti A, et al., Genes, lifestyles and obesity. International Journal of Obesity, 2004.
28(S3): p. 29-36.
78. Javaras K, et al., Familiality and heritability of binge eating disorder: Results of a case‐
control family study and a twin study. International Journal of Eating Disorders, 2008.
41(2): p. 174-179.
79. Institute of Medicine (US): Committee on Pain, and Chronic Illness Behavior. Pain and
disability: clinical, behavioral, and public policy perspectives. 1987: Washington (DC).
80. Heller R, et al., Lifestyle factors in monozygotic and dizygotic twins. Genetic
Epidemiology, 1988. 5(5): p. 311-321.
81. Battié M, et al., Heritability of low back pain and the role of disc degeneration. Pain,
2007. 131(3): p. 272-280.
82. El-Metwally A, et al., Genetic and environmental influences on non-specific low back
pain in children: a twin study. European Spine Journal, 2008. 17(4): p. 502-508.
83. Anand S, The value of studying gene-environment interactions in culturally diverse
populations. Canadian Journal of Physiology and Pharmacology, 2005. 83(1): p. 42-46.
84. Temelkova-Kurktschiev T, et al., Lifestyle and genetics in obesity and type 2 diabetes.
Experimental and Clinical Endocrinology & Diabetes, 2012. 120(01): p. 1-6.
85. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2
diabetes with lifestyle intervention or metformin. New England Journal of Medicine,
2002. 346(6): p. 393-403.
86. Alegría-Torres J, et al., Epigenetics and lifestyle. 2011.
87. Huppertz C, et al., Effect of shared environmental factors on exercise behavior from age
7 to 12 years. Medicine and Science in Sports and Exercise, 2012. 44(10): p. 2025-2032.
23
88. Steinle N, et al., Eating behavior in the old order Amish: Heritability analysis and a
genome-wide linkage analysis. The American Journal of Clinical Nutrition, 2002. 75(6):
p. 1098-1106.
89. Wong C, et al., A longitudinal study of epigenetic variation in twins. Epigenetics, 2010.
5(6): p. 516-526.
90. van Dijk S, et al., Epigenetics and human obesity. International Journal of Obesity, 2015.
39(1): p. 85-97.
91. Denk F, et al., Chronic pain: emerging evidence for the involvement of epigenetics.
Neuron. 73(3): p. 435-444.
92. Buchheit T, et al., Epigenetics and the transition from acute to chronic pain. Pain
Medicine, 2012. 13(11): p. 1474-1490.
93. Dempster E, et al., Disease-associated epigenetic changes in monozygotic twins
discordant for schizophrenia and bipolar disorder. Human Molecular Genetics, 2011.
94. Peltonen L, et al., Classical twin studies and beyond. Nature Reviews Genetics, 2002.
3(11): p. 872-882.
95. Malkin I, et al., Low back and common widespread pain share common genetic
determinants. Annals of Human Genetics, 2014. 78(5): p. 357-366.
96. Hestbaek L, et al., Heredity of low back pain in a young population: A classical twin
study. Twin Research, 2004. 7(01): p. 16-26.
97. Hopper J, The epidemiology of genetic epidemiology. Acta Geneticae Medicae et
Gemellologiae, 1992. 41(4): p. 261-273.
98. International Genetic Epidemiology: American Society of Human. Genetic epidemiology.
2011. 
24
99. Hall J, Twinning. The Lancet, 2003. 362(9385): p. 735-743.
100. Prentice A, et al., Beyond body mass index. Obesity Reviews, 2001. 2(3): p. 141-147. 
101. World Health Organization. Appropriate body-mass index for Asian populations and its 
implications for policy and intervention strategies. The Lancet. 363(9403): p. 157-163. 
102. Dandinasivara, et al., Beyond body mass index – Our experience with body composition 
estimations. Obesity Research & Clinical Practice, 2012. 6: p. 67. 
103. Luke A, Ethnicity and the BMI–body fat relationship. British Journal of Nutrition, 2009. 
102(4): p. 485-487. 
104. Deurenberg P, et al., The validity of predicted body fat percentage from body mass index 
and from impedance in samples of five European populations. European Journal of 
Clinical Nutrition, 2001. 55(11): p. 973. 
105. Gorber S, et al., Diagnostic in obesity comorbidities: A comparison of direct vs. self-
report measures for assessing height, weight and body mass index: A systematic review. 
Obesity Reviews, 2007. 8(4): p. 307-326. 
106. Janssen I, et al., Waist circumference and not body mass index explains obesity-related 
health risk. The American Journal of Clinical Nutrition, 2004. 79(3): p. 379-384. 
107. Janssen I, et al., Body mass index, waist circumference, and health risk: Evidence in 
support of current National Institutes of Health guidelines. Archives of Internal 
Medicine, 2002. 162(18): p. 2074-2079. 
108. Kanaya A, et al., Association of total and central obesity with mortality in 
postmenopausal women with coronary heart disease. American Journal of Epidemiology, 
2003. 158(12): p. 1161-1170. 
25
109. Yusuf S, et al., Obesity and the risk of myocardial infarction in 27,000 participants from
52 countries: A case-control study. The Lancet, 2005. 366(9497): p. 1640-1649.
110. Toda Y, et al., Lean body mass and body fat distribution in participants with chronic low
back pain. Archives of Internal Medicine, 2000. 160(21): p. 3265-3269.
111. Urquhart D, et al., Increased fat mass is associated with high levels of low back pain
intensity and disability. Spine, 2011. 36(16): p. 1320-1325.
112. Leahy S, et al., A comparison of dual energy X-ray absorptiometry and bioelectrical
impedance analysis to measure total and segmental body composition in healthy young
adults. European Journal of Applied Physiology, 2012. 112(2): p. 589-595.
113. Völgyi E, et al., Assessing body composition with DXA and bioimpedance: Effects of
obesity, physical activity, and age. Obesity, 2008. 16(3): p. 700-705.
114. Dalton M, et al., Waist circumference, waist–hip ratio and body mass index and their
correlation with cardiovascular disease risk factors in Australian adults. Journal of
Internal Medicine, 2003. 254(6): p. 555-563.
115. Esser N, et al., Inflammation as a link between obesity, metabolic syndrome and type 2
diabetes. Diabetes Research and Clinical Practice, 2014. 105(2): p. 141-150.
116. Mäntyselkä P, et al., Glucose regulation and chronic pain at multiple sites.
Rheumatology, 2008. 47(8): p. 1235-1238.
117. Mäntyselkä P, et al., Chronic pain, impaired glucose tolerance and diabetes: A
community-based study. Pain, 2008. 137(1): p. 34-40.
118. Briggs M, et al., Relations of C-reactive protein and obesity to the prevalence and the
odds of reporting low back pain. Archives of Physical Medicine and Rehabilitation,
2013. 94(4): p. 745-752.
26
119. Molsted S, et al., Musculoskeletal pain in patients with type 2 diabetes. Diabetes 
Research & Clinical Practice, 2012. 96(2): p. 135-140. 
120. Licciardone J, et al., Osteopathic manual treatment in patients with diabetes mellitus and 
comorbid chronic low back pain: Subgroup results from the OSTEOPATHIC Trial. The 
Journal of the American Osteopathic Association, 2013. 113(6): p. 468-478. 
121. Ritzwoller D, et al., The association of comorbidities, utilization and costs for patients 
identified with low back pain. BioMed Central Musculoskeletal Disorders, 2006. 7(1): p. 
1-10. 
122. Willemsen G, et al., The concordance and heritability of type 2 diabetes in 34,166 
twin pairs from international twin registers: The Discordant Twin (DISCOTWIN) 
Consortium. Twin Research and Human Genetics, 2015. 18(6): p. 762-771. 
123. Videman T, et al., Disc degeneration and bone density in monozygotic twins discordant 
for insulin-dependent diabetes mellitus. Journal of Orthopaedic Research, 2000. 18(5): p. 
768-772. 
27
CHAPTER TWO 
The relationship between obesity, low back pain, and lumbar disc 
degeneration when genetics and the environment are considered: 
A systematic review of twin studies 
Reprinted from: The Spine Journal, volume 15, Dario, A.B., et al., The relationship between 
obesity, low back pain, and lumbar disc degeneration when genetics and the environment are 
considered: a systematic review of twin studies, page numbers 1106-1117, 2015, with permission 
from Elsevier.  
28
AUTHORSHIP STATEMENT 
The co-authors of the paper “The relationship between obesity, low back pain, and lumbar 
disc degeneration when genetics and the environment are considered: a systematic review of 
twin studies” confirm that Amabile Borges Dario has made the following contributions: 
• Conception and design of the research
• Extraction of data
• Analysis and interpretation of the findings
• Drafting and revising of the manuscript and critical appraisal of content
As the primary supervisor for the candidature upon which this thesis is based, I can confirm that 
the above authorship attribution statement is correct.  
...................................................................... 
Associate Professor Paulo Henrique Ferreira 
The University of Sydney  
December 2016 
29
The Spine Journal 15 (2015) 1106–1117Review Article
The relationship between obesity, low back pain, and lumbar disc
degeneration when genetics and the environment are considered:
a systematic review of twin studies
Amabile B. Dario, MSca,*, Manuela L. Ferreira, PhDb, Kathryn M. Refshauge, PhDa,
Thais S. Lima, MScc, Juan R. Ordo~nana, PhDd,e, Paulo H. Ferreira, PhDa
aDiscipline of Physiotherapy, Faculty of Health Sciences, The University of Sydney, PO Box 170, 75 East Street Lidcombe, Sydney, NSW, Australia 2141
bThe George Institute for Global Health and Institute of Bone and Joint Research, Kolling Institute, Sydney Medical School, The University of Sydney,
Level 13, 321 Kent Street, Sydney, NSW, Australia 2141
cBiomechanics and Motor Control Research Group, Science and Technology Faculty-Universidade Estadual Paulista, Presidente Prudente,
Sao Paulo, Brazil 19060-900
dMurcia Twin Registry, Department of Human Anatomy and Psychobiology, University of Murcia, Spain 30100
eIMIB-Arrixaca, Department of Human Anatomy and Psychobiology, Murcia, Spain 30100
Received 15 September 2014; revised 13 January 2015; accepted 1 February 2015Abstract BACKGROUND CONTEXT: The relationshFDA device/drug
Author disclosure
close. KMR: Nothing
to disclose. PHF: No
Funding sources:
ence without Borders
http://dx.doi.org/10.10
1529-9430/ 2015 Eips between obesity and low back pain (LBP) and
lumbar disc degeneration (LDD) remain unclear. It is possible that familial factors, including genet-
ics and early environment, affect these relationships.
PURPOSE: To investigate the relationship between obesity-related measures (eg, weight, body
mass index [BMI]) and LBP and LDD using twin studies, where the effect of genetics and early
environment can be controlled.
STUDY DESIGN: A systematic review with meta-analysis.
METHODS: MEDLINE, CINAHL, Scopus, Web of Science, and EMBASE databases were
searched from the earliest records to August 2014. All cross-sectional and longitudinal observational
twin studies identified by the search strategy were considered for inclusion. Two investigators inde-
pendently assessed the eligibility, conducted the quality assessment, and extracted the data. Metaa-
nalyses (fixed or random effects, as appropriate) were used to pool studies’ estimates of association.
RESULTS: In total, 11 articles met the inclusion criteria. Five studies were included in the
LBP analysis and seven in the LDD analysis. For the LBP analysis, pooling of the five studies
showed that the risk of having LBP for individuals with the highest levels of BMI or weight was
almost twice that of people with a lower BMI (odds ratio [OR] 1.8; 95% confidence interval
[CI] 1.6–2.0; I250%). A dose-response relationship was also identified. When genetics and
the effects of a shared early environment were adjusted for using a within-pair twin case-
control analysis, pooling of three studies showed a reduced but statistically positive association
between obesity and prevalence of LBP (OR 1.5; 95% CI 1.1–2.1; I250%). However, the asso-
ciation was further diminished and not significant (OR 1.4; 95% CI 0.8–2.3; I250%) when
pooling included two studies on monozygotic twin pairs only. Seven studies met the inclusion
criteria for LDD. When familial factors were not controlled for, body weight was positively as-
sociated with LDD in all five cross-sectional studies. Only two cross-sectional studies investi-
gated the relationship between obesity-related measures and LDD accounting for familial
factors, and the results were conflicting. One longitudinal study in LBP and three longitudinal
studies in LDD found no increase in risk in obese individuals, whether or not familial factors
were controlled for.status: Not applicable.
s: ABD: Nothing to disclose. MLF: Nothing to dis-
to disclose. TSL: Nothing to disclose. JRO: Nothing
thing to disclose.
The author ABD is supported by the program ‘‘Sci-
,’’ Brazil.
Conflict of interest: The authors declare that they have no competing
interests.
* Corresponding author. Faculty of Health Sciences, University of Syd-
ney, PO Box 170, Lidcombe 1825, Australia. Tel.: (61) 293-519-562; fax:
(61) 293-519-601.
E-mail address: adar3900@sydney.edu.au (A.B. Dario)
16/j.spinee.2015.02.001
lsevier Inc. All rights reserved. 30
1107A.B. Dario et al. / The Spine Journal 15 (2015) 1106–1117CONCLUSIONS: Findings from this review suggest that genetics and early environment are pos-
sible mechanisms underlying the relationship between obesity and LBP; however, a direct causal
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sity, LBP, and LDD.  2015 Elsevier Inc. All rights reserved.Keywords: Obesity; Body mass index; Body weight; Low back pain; Lumbar disc degeneration; Genetics; TwinsIntroduction
Low back pain (LBP) is a major health problem globally
[1], being the largest contributor to the number of years that
people live with disability [2]. Although decades of re-
search have been dedicated to identifying the etiology of
LBP, the factors that trigger an episode of LBP remain un-
clear [3], limiting the possibility of designing effective pre-
ventative strategies. A variety of factors have inconsistently
been found to be associated with LBP, and the increased
risk has been small. One of these factors, obesity, is a po-
tential target for prevention strategies, and therefore, it
has been the focus of several studies in the field [4,5].
Obesity is recognized as a major public health problem,
and its prevalence is increasing rapidly in westernized
countries [6,7]. Obese individuals are at higher risk of de-
veloping a wide spectrum of chronic diseases such as dia-
betes, cardiovascular disease, cancer, and musculoskeletal
disorders, such as spinal problems [8]. Body weight, an im-
portant factor related to spinal loading, has been associated
with several signs of lumbar disc degeneration (LDD),
including disc space narrowing [9] and decreased signal
intensity of the lumbar intervertebral discs [10]. Despite
controversy [11–13], LDD has been proposed as one of
the main risk factors of LBP [10,14].
Previous studies have suggested that familial factors (ie,
early environmental and genetic influences) play an impor-
tant role on obesity, LBP, and LDD. According to twin
studies, the estimated contribution from heritability for to-
tal body fat ranges between 70% and 80% [15], for LBP be-
tween 30% and 46% [16], and for LDD the contribution
ranges between 47% and 60% [14], suggesting a major ge-
netic component in these conditions. However, most studies
that investigated the relationship between obesity, LBP, and
LDD did not account for genetic or early environmental
factors, which might explain their conflicting findings.
Twin studies represent a unique and powerful design for
investigating risk factors for health conditions as they allow
controlling for various confounders, including genetic fac-
tors, consequently providing more precise estimates of risk.
To our knowledge, there has been no published systematic
review specifically investigating the relationship between
obesity, LBP, and LDD in twin studies. Therefore, this
systematic review aimed to investigate whether there is
an association between obesity and LBP and obesity and
LDD, and whether this association is influenced by genetics
and early environment.Methods
A review protocol was registered in the ‘‘International
prospective register of systematic reviews’’ under the
registration number CRD42014005747. We used the Meta-
analysis of Observational Studies in Epidemiology guide-
lines to lead each section of this systematic review [17].
Search strategy
MEDLINE, CINAHL, Scopus, Web of Science, and
EMBASE databases were searched using a combination
of key words related to obesity, LBP, and LDD. The search
was conducted from the earliest records to August 2014 to
identify cross-sectional and longitudinal observational twin
studies that investigated the obesity-LBP and obesity-LDD
relationships. Additionally, citation tracking was conducted
of the reference list of included studies and relevant publi-
cations in the field. If additional clarification or data were
required, authors were contacted by email.
Selection of studies
All articles identified by the search strategy were inde-
pendently screened by two investigators (ABD and TL),
with a third independent investigator (PHF) resolving any
disagreement. The assessment involved three stages:
screening of titles, abstracts, and full text. The number of
studies identified was recorded for all screening stages.
Inclusion and exclusion criteria
We included cross-sectional and longitudinal observatio-
nal studies that investigated the relationship between obesity
and LBP and obesity and LDD using twins, where the ge-
netic and early shared environment components were or
were not adjusted for (case-control studies and studies that
recruited twin samples, respectively). Twins needed to ac-
count for at least 90% of the total sample, with no restriction
on age, gender, or zygosity. No restriction was applied on
the year of publication or language. Studies were excluded
if they investigated specific spinal pathologies (fracture,
cancer, and systemic diseases) or pregnancy-related LBP.
Exposure factors
The exposure factors were obesity or a measure of obe-
sity such as body mass index (BMI), percent fat mass, or
weight.31
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The outcomes of interest were present occurrence (prev-
alence) of LBP or LDD in cross-sectional studies and future
occurrence (incidence) of LBP and LDD in longitudinal
studies. All definitions for LBP were accepted, as these var-
ied considerably among studies. For LDD, studies were in-
cluded if the outcome was a pathoanatomical finding based
on imaging, such as disc space narrowing or changes in disc
signal.Data extraction
Data were extracted from all included studies regarding
participants, sampling methods, response rates, length of
follow-up, and information on exposure factors (obesity-re-
lated measures) and potential confounders (eg, gender,
age). A standardized form developed for this systematic re-
view was used to extract data. When studies performed lon-
gitudinal and cross-sectional analyses, data from both
analyses were extracted. When studies reported more than
one cross-sectional analysis, estimates were extracted from
the analysis with the largest sample size. We extracted es-
timators such as odds ratios (ORs) and measurements of
variability for the associations between obesity and both
LBP and LDD. To investigate if genetics and early shared
environment factors affected these associations, data from
studies reporting results from the total sample and from
case-control analyses were extracted separately. In the total
sample analysis, no adjustment for genetics or early shared
environment factors was performed and twins were ana-
lyzed as individuals rather than pairs, irrespective of dis-
cordance for LBP within twin pairs. The case-control
analysis included only complete twin pairs who were dis-
cordant for LBP status, that is, one twin reported LBP,
whereas the other did not.
This approach enabled control of various confounders,
including genetic factors and twins’ early shared environ-
mental factors. It was assumed that the case-control design
allowed clear identification of a relationship between an
outcome (eg, LDD) and an exposure factor (eg, BMI) be-
cause it controls for genetic factors and early shared envi-
ronment. Theoretically, when the magnitude of the
association between two variables (eg, LDD and BMI) in-
creases from the total sample analysis (no adjustment for
genetic factors or early shared environment) to a monozy-
gotic (MZ) case-control analysis (adjustment for early
shared environment and approximately 100% of genetic
factors), the relationship between the two variables is more
direct and possibly more consistent with a direct causal
path [18].Methodologic quality
The quality of included studies was assessed using a
standardized checklist based on the recommendations for
publishing a systematic review [19,20] and the STROBE(Strengthening the Reporting of Observational Studies in
Epidemiology Statement) guidelines [21]. The checklist
comprised eight criteria: representative sample, defined
sample, blinding of assessors to the predictor, blinding of
assessors to the outcome, follow-up rate greater than
85%, defined method of assessment, reporting on outcome
data, and statistical adjustment for potential confounders.
Two members (ABD and TL) of the research team con-
ducted the critical appraisal independently. Results were
compared and disagreements were resolved by the third in-
dependent investigator (PHF).
Meta-analysis
Extracted estimates of risk and confidence intervals (CIs)
were synthesized in a meta-analysis, when the data reported
were sufficiently homogenous. Where studies provided
results for more than one description of LBP, we chose the
definition that involved longer andmore disabling symptoms
(eg, chronic instead of acute LBP). When predictors were
presented in incremental categories, we selected the cate-
gory with higher levels of exposure for the meta-analysis.
Dose-response relationship was calculated when studies
provided estimated risks for different levels of exposure
(eg, overweight and obesity). For those studies with different
degrees of control for confounders, we used the model that
adjusted for the greatest number of variables. We used the
lowest available anthropometric level for weight or the nor-
mal category for BMI as the reference category. Data were
pooled using Comprehensive Meta-Analysis software, ver-
sion 2.2.064 (Biostat, Englewood, USA, 2008). Study heter-
ogeneity was analyzed using visual inspection of graphs and
the I2 statistic. True homogeneity was considered to be I250,
low heterogeneity lower than 30%, moderate 30% to 49%,
substantial 50% to 74%, and considerable heterogeneity
greater than 75% [22]. In case of heterogeneity equal to or
higher than substantial, a random effects model was used
to calculate the pooled OR estimates and their variances.Results
Included studies
The systematic search identified 822 publications, 769
were removed after screening for duplicates and ineligible
titles and abstracts (Fig. 1). Fifty-three studies were identi-
fied as potentially eligible and, after full-text screening, 11
publications met our inclusion criteria and were included in
the review [4,5,14,23–30]. One study reported data for LBP
and LDD [26]. The included studies were published be-
tween 1999 and 2011. The total number of participants
from studies assessing LBP and LDD was 45,784 and
4,205, respectively. Included studies recruited twins from
registries in the United States [5], Finland [14,23–25,27],
Australia [28], United Kingdom [26,28,30], and Denmark
[4,29]. Comprehensive descriptions are provided in32
Fig. 1. Selection of the included studies. LBP, low back pain; LDD, lumbar disc degeneration.
1109A.B. Dario et al. / The Spine Journal 15 (2015) 1106–1117Table 1 for studies investigating the relationship between
obesity and LBP symptoms and in Table 2 for obesity
and LDD [31].
Methodologic quality
A summary of the methodologic quality of included
studies is shown in Table 3. All five (100%) studies inves-
tigating LBP had a representative and well-defined sample,
well-defined method of assessment of predictors and out-
comes, and reported outcome data and conducted adjust-
ment for potentially confounding factors. One study did
not include blinded assessors for predictors and outcomes
[26], and the only included longitudinal study had a
follow-up rate below 85% [29]. For LDD, six (86%) studies
had a representative sample and all seven (100%) defined
the sample and the method of assessment of predictors
and outcomes. Assessors were blinded for predictors in
six (86%) and for outcomes in five (71%) studies. Four
(57%) of the studies reported outcome data and adjusted
the analysis for potentially confounding factors. Two ofthe three longitudinal studies for LDD had a follow-up rate
below 85%.
Assessment and definition of obesity-related measures
The most common measure of obesity in the included
studies was BMI [4,5,26,28,29]. The second most common
measure was body weight [14,24–27,30], followed by per-
centage of body fat [24] and intrinsic disc loading (esti-
mated by body weight divided by the axial spinal disc
area) [23]. The definition and cutoff points used in each
study are provided in Table 1 and Table 2 (LBP and LDD
studies, respectively).
Assessment and definition of LBP and LDD
Low back pain was assessed by questionnaires with a
body chart in all [4,26,29,30] except one study [5]. Low
back pain was defined as pain, stiffness, and discomfort
in the lumbar area accompanied [26,30] or not [4,5,29]
by disability. Duration of pain and disability ranged from33
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months [5]. Magnetic resonance imaging was used in all
studies to identify LDD through qualitative assessment
[14,24,26,28] or a combination of qualitative and quantita-
tive assessments [23,25,27]. The phenotype of LDD was
characterized by decreased disc height [14,23–28] or disc
signal intensity [14,24–28], disc bulging [14,23,25–28], os-
teophytes [14,26,28], disc irregularity [14,23], disc hernia-
tion [14], or a combination of different parameters [26,28].
Association between obesity-related measures and LBP
symptoms
Results of studies reporting total sample analyses
Five studies investigated the relationship between
obesity-related measures (ie, BMI and body weight) and
LBP using total samples of twins with no adjustment for
familial factors [4,5,26,29,30]. All studies reported suffi-
cient and similar data to be pooled in a meta-analysis. Pool-
ing of the data (Fig. 2) revealed that twins classified in the
highest level of BMI or weight had 1.8 times increased
odds of having LBP (OR 1.8; 95% CI 1.6–2.0; p5.001;
I250%) compared with those with normal or lighter body
weight. Pooling of longitudinal data was not possible as on-
ly one study was identified. This study, conducted in Den-
mark, followed participants for 8 years, finding no effect of
BMI on LBP incidence (OR 1.0; 95% CI 0.9–1.4) [29].
Obesity-LBP dose-response relationship
A possible dose-response relationship between obesity-
related measures (weight or BMI) and LPB was investi-
gated in four studies [4,5,29,30]. Pooling of the four studies
(Fig. 2) revealed that the prevalence of LBP in obese twins
(OR 1.8; 95% CI 1.6–2.0; p5.001; I250%) was higher than
the prevalence of LBP in overweight twins (OR 1.5; 95%
CI 1.3–1.7; p5.001; I2555%). In addition, one study found
that twins who were underweight had a lower prevalence of
LBP than twins who had normal values of BMI (OR 0.7;
95% CI not reported) [4].
Results of studies reporting analyses that accounted for ge-
netic and early environmental factors
A total of four studies investigated the effect of genetic
factors and early shared environment on the LBP-obesity
relationship [4,5,29,30]. Three [4,5,29] studies conducted
a within-pair case-control analysis, where twin pairs dis-
similar for body weight (one twin classified as normal
weight and the other as overweight or obese) were ana-
lyzed. Pooling of these twin studies showed a statistically
significant positive association between obesity/overweight
and prevalence of LBP (OR 1.5; 95% CI 1.1–2.1; p5.02;
I250%). However, when pooling included case-control
studies with MZ twins only [4,29], the association was no
longer statistically significant (OR 1.4; 95% CI 0.8–2.3;
p5.26; I250%). The only longitudinal study that used a
within-pair case-control design did not identify a significant35
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95% CI 0.3–2.6) [29] (Fig. 3).
Association between obesity and LDD
Despite seven studies [14,23–28] having investigated the
association between obesity-related measures and signs of
LDD, a meta-analysis was not feasible because of the het-
erogeneity in study estimates of association or lack of out-
come data.
Results of studies reporting total sample analyses
Signs of LDD such as disc height narrowing, bulging,
and signal intensity were associated with increased body
weight [23,25,28]. Body weight and intrinsic load in the
L1–L4 discs explained between 1.4% [26] and 17% [23]
of the variance in signs of lumbar degeneration. Three lon-
gitudinal studies investigating the effect of obesity in the
progression of LDD did not find any increase in risk of de-
veloping LDD over 5 [14,27] or 10 years [28].
Results of studies reporting analyses that accounted for ge-
netic and early environmental factors
Only two studies, both cross-sectional, that investigated
the relationship between obesity-related measures and LDD
accounted for genetic and early environmental factors
[24,28]. One study used a within-pair MZ case-control
analysis and found that heavier twin had 5.4% higher disc
signal variation (a measure of water concentration in inter-
vertebral discs) in L1–L4 intervertebral discs compared
with the lighter co-twin. [24].
In pairs of same-sex twins [28], a positive association
between BMI and LDD was found for the total twin sample
(OR 1.2; 95% CI 1.1–1.4) and for dizygotic (DZ) twins
(OR 1.2; 95% CI 1.2–1.7), but not for MZ twins (OR
0.9; 95% CI 0.6–1.3) [28]. A cross-sectional analysis of
the 10-year follow-up data showed that BMI was associated
with LDD in the total sample analysis (OR 1.3; 95% CI
1.2–1.5) and in both DZ (OR 1.3; 95% CI 1.0–1.5) and
MZ (OR 1.6; 95% CI 1.1–2.3) twins.Discussion
Main findings
It is known that familial factors (genetic and early envi-
ronment) play a significant role in obesity, LBP, and LDD
[15,16,32]. However, there is limited evidence to examine
whether familial factors affect a potential relationship be-
tween obesity and both LBP and LDD [33]. Twin studies,
particularly using a within-pair twin case-control design,
have the potential to provide less biased estimates of risk
for a condition by controlling for possible confounding
from genetic factors and early shared environment [34].
We aimed to review and summarize the evidence from twin
studies that investigated the effect of obesity-related37
Table 3
Methodologic quality assessment of included studies
Study
Sources of bias
Appropriate measure
of variables Confounding
Representative
sample*
Defined
sampley
Assessor
blinded
to predictorz
Assessor
blinded
to outcomex
Follow-up
rateO85%jj
Methods of
assessment{
Outcome
data
reported#
Statistical
adjustment**
Low back pain
Leboeuf-Yde et al. [4], 1999 Y Y Y Y N/A Y Y Y
MacGregor et al. [30], 2004 Y Y Y Y N/A Y Y Y
Hestbaek et al. [29], 2006 Y Y Y Y N Y Y Y
Wright et al. [5], 2010 Y Y Y Y N/A Y Y Y
Livshits et al. [26], 2011 Y Y N N N/A Y Y Y
Lumbar disc degeneration
Videman et al. [14], 2006 Y Y Y Y Y Y N N
Battie et al. [25], 2008 Y Y Y Y N/A Y N N
Videman et al. [23], 2008a Y Y Y Y N Y N N
Videman et al. [27], 2008b Y Y N N N/A Y Y Y
Videman et al. [24], 2010 N Y Y N N/A Y Y Y
Livshits et al. [26], 2011 Y Y Y Y N/A Y Y Y
Williams et al. [28], 2011 Y Y Y Y N Y Nyy Y
Y, yes; N, no; N/A, not applicable.
* Participants were selected as consecutive or random cases.
y Description of participant source and inclusion and exclusion criteria.
z Assessor unaware of the predictor of the study.
x Assessor/patient (self-reported questionnaire) unaware of at least one outcome of the study.
jj Outcome data were available for at least 85% of participants at one follow-up point.
{ Standardized and fully defined method to assess the predictor and outcome.
# Raw data, percentages, p value, risk estimates reported, and confidence interval.
** Multivariate analysis conducted with adjustment for potentially confounding factors.
yy Authors provided supplementary data after requested.
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or were not controlled for. The results of this systematic re-
view suggest that individuals who are obese or overweight
are more likely to have LBP and LDD than those who are in
the normal weight range or underweight. However, after
controlling for familial factors, the associations between
obesity-related measures and LBP appear to diminish and
are no longer evident after full adjustment in MZ twins. Re-
sults from the longitudinal studies showed evidence that
obesity-related measures do not increase the risk for LBP
or LDD, irrespective of adjustment for familial effects.Obesity and LBP
The magnitude of association between obesity and LBP
found in this review was weak (OR51.8) according to the
benchmarks used for observational studies [35]. However, re-
sults tended to be consistent in all five twin studies with sam-
ples from four different countries and participants’ ages
ranging from 12 to 84 years. Our meta-analysis also identified
a dose-response relationship between obesity and LBP. These
findings are consistent with results from previous metaanaly-
ses, in which a similar effect sizewas found for the association
betweenobesity and prevalenceofLBP in individuals from the
general population [34,36] and a similar dose-response rela-
tionship [36]. Although these results tend to support the poten-
tial for a causal relationship between obesity and LBP, thecriteria for the temporal relationship required to demonstrate
causation has not been fulfilled in our review.We identifiedon-
ly one longitudinal study and that study did not identify any in-
creased incidence of LBP in obese individuals. Similarly, no
effect was found of obesity on LPB incidence in samples from
the general population [37,38].
The obesity-LBP association is only apparent in cross-
sectional studies, however, the inverse relationship, that
is, LBP leading to obesity, should not be disregarded. Evi-
dence from a nontwin study suggests that individuals with
LBP, particularly chronic pain, tend to gain more weight
than those with no symptoms of pain [39]. Therefore, to
better understand the interaction between obesity and
LBP, further investigation of the direction of the associa-
tion should be conducted in longitudinal studies using a
twin design.
Another interesting finding of our review was the small
and nonsignificant association (OR 1.4; 95% CI 0.8–2.3;
p5.26) between obesity and LBP observed in the MZ anal-
ysis when compared with the total sample analysis. This
pattern of reduced association was consistent across all in-
cluded studies that adjusted for genetic factors and with our
own unpublished data from our research group in 156 MZ
Spanish twins dissimilar for LBP status. Although we can-
not rule out the possibility of this finding being a reflection
of smaller samples and larger CIs, the imprecision of the
data is unlikely to be the reason. The pooled MZ analysis38
Fig. 2. Pooled ORs of all included cross-sectional studies that investigated the relationship between obesity and low back pain without adjustment for genetic
factors or shared early environment. Pooling is stratified by incremental levels of exposure. Squares represent each individual study. Diamonds represent the
pooled effect. Weight % represents the influence of each study in the overall meta-analysis. OR, odds ratio; CI, confidence interval; I2, heterogeneity of studies.
1115A.B. Dario et al. / The Spine Journal 15 (2015) 1106–1117included a large sample of 469 twin pairs (938 individuals).
These twin pairs were matched for age, sex, and genetic
factors, in addition to twins’ early shared environmental
factors. By controlling for these confounders, the MZ anal-
ysis potentially provides a more precise estimate than the
total sample analysis. In sum, the trend toward progressive
reduction in the association across the phases (total sample:
OR 1.8; DZ/MZ twins together: OR 1.5; MZ twins: OR 1.4)
suggests that genetic factors and early environment shared
by twins are possibly confounding the association between
obesity and LBP.Obesity and LDD
Positive associations between body weight and LDD
were consistently present in the total sample analyses of
all four cross-sectional studies included in our review
[23,25,26,28]. However, there was no temporal effect of
body weight on the progression of LDD; the risk of LDD
was not increased in overweight or obese individuals in
any of the three longitudinal studies [14,27,28]. Our resultsFig. 3. Pooled ORs of all included cross-sectional within-pair case-control studie
represent each individual study. Diamonds represent the pooled effect of obesity
overall meta-analysis. OR, odds ratio; CI, confidence interval; I2, heterogeneityare partially in agreement with observational studies that
used samples from the general population. Although one
longitudinal study with a 20-year follow-up concluded that
body weight did not increase the risk of LDD measured us-
ing plain X-ray (OR 1.1; 95% CI 0.3–3.6; p5.90) [40], an-
other study with a four-year follow-up showed that
overweight individuals (BMIO25 kg/m2) at the age of 25
years had higher risks of developing LDD 4 years later
(OR 4.3; 95% CI 1.3–14.3) [10].
In the present review, the effects of familial factors on
the obesity-LDD relationship were only examined in two
cross-sectional studies [24,28]. While one study found that
the heavier MZ twin (at least 8 kg heavier than the co-twin)
had a lower prevalence of LDD, the other study [28] found
the body weight-LDD association to be present in the total
sample and in DZ twins, but the association disappeared in
MZ twins at a younger age. It is plausible to suggest that
the effects of genetic factors on the obesity-LDD relation-
ship are stronger earlier in life. Interestingly, the heritability
of progression of LDD has been found to be mainly influ-
enced by genetic factors at younger age [28].s investigating the relationship between obesity and low back pain. Squares
on low back pain. Weight % represents the influence of each study in the
of studies; MZ, monozygotic twin pairs; DZ, dizygotic twin pairs.
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research
Currently there is uncertainty regarding the signifi-
cance of obesity as a risk factor for LBP and LDD.
Therefore, a recommendation to intervene to reduce obe-
sity for the purpose of reducing LBP is not yet warranted
in clinical guidelines. Inadequate control for familial fac-
tors is a possible explanation for conflicting results in
this field. We found evidence that familial factors poten-
tially influence the obesity-LBP association. The results
of this review provide a different perspective on the rela-
tionship between obesity and LBP. The identification, in
future research, of specific genes or early shared environ-
mental factors (eg, diet, engagement in physical activity)
that influence both obesity and LBP might reveal new
mechanisms underlying this relationship and could, in
turn, lead to effective preventative strategies. We advo-
cate that future high-quality longitudinal research, pref-
erably using a within-pair twin case-control design, is
an ideal method to understand this relationship more
precisely.
Strengths and limitations
One of the main strengths of this review is the inclusion
of twin studies that facilitates insights into causal relation-
ships between variables. The case-control analysis of
twin studies allows the investigation of a more direct rela-
tionship between obesity and both LBP and LDD by
controlling for possible genetic and early environmental
confounding. This design also has the potential to provide
more precise estimates of risks for a disease. The inclusion
of a dose-response analysis was a unique feature in our re-
view, which provides further insights into a possible causal
relationship between obesity and LBP. Overall, the quality
of included studies was high (mean: 83.3%) for LBP and
LDD. We were also able to provide an efficient summary
of results of twin studies by pooling the estimates of the
relationship between obesity-related measures and LBP.
Unfortunately, included studies were too heterogeneous
for the measures of LDD and this precluded pooling of
data. Also, the effect of familial factors was mostly avail-
able in cross-sectional studies that assessed LBP as the
outcome.Conclusion
Although obesity is commonly reported to be a risk fac-
tor for LBP, our results do not support a direct causal rela-
tionship between obesity and LBP. Genetic factors and
early environment are possible factors influencing this rela-
tionship. Further longitudinal studies using the twin design
are needed to better understand the complex mechanisms
underlying the association between obesity and LBP and
obesity and LDD.References
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Abstract
Purpose To investigate the relationship between different
measures of obesity and chronic low back pain (LBP) using
a within-pair twin case–control design that adjusts for
genetics and early shared environment.
Methods A cross-sectional association between lifetime
prevalence of chronic LBP and different measures of
obesity (body mass index-BMI; percent body fat; waist
circumference; waist–hip ratio) was investigated in 1128
female twins in three stages: (i) total sample analysis; (ii)
within-pair case–control analysis for monozygotic (MZ)
and dizygotic (DZ) twins together; (iii) within-pair case–
control analysis separated by DZ and MZ. Odds ratios
(OR) and 95 % confidence intervals (CI) were calculated.
Results BMI (OR 1.12; 95 % CI 1.02–1.26) and percent
body fat (OR 1.15; 95 % CI 1.01–1.32) were weakly
associated with lifetime prevalence of chronic LBP in the
total sample analysis but were absent when shared envi-
ronment and genetic factors were adjusted for using the
within-pair case–control analysis. Greater waist–hip ratios
were associated with smaller prevalence estimates of
chronic LBP in the within-pair case–control analysis with
both MZ and DZ twins (OR 0.67; 95 % CI 0.47–0.94).
However, this association did not remain after the full
adjustment for genetic factors in the MZ within-pair case–
control analysis.
Conclusions BMI, percent of fat mass and greater depo-
sitions of fat and mass around the hips are associated with
increases in chronic LBP prevalence in women but these
associations are small and appear to be confounded by the
effects of genetics and early shared environment. There-
fore, our results do not support a causal direct relationship
between obesity and chronic LBP.
Keywords Obesity  Low back pain  Genetics  Twins
Introduction
Obesity is a pandemic and growing public health concern
[1]. It is recognized as the main public health problem in
industrialized countries [2] and is linked to morbidity and
high mortality rates [1]. Obesity has also been found to be
associated with various musculoskeletal disorders, includ-
ing low back pain (LBP) [3].
LBP is common with the 1-month prevalence being
estimated as 23.2 % (95 % CI 20.3–26.1). It is the highest
contributor to the number of years that people live with
disability in the world [4]. LBP is more common in women
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than in men [5] and little is understood about its etiology
[6]. There is a consensus in the field that research efforts
need to be allocated to the investigation of causes and risk
factors for LBP, as this understanding is crucial for effec-
tive prevention [7]. From a public health perspective, it
would be important to know if lifestyle factors, such as
excessive body weight, are contributors to LBP incidence
especially when considering that obesity is a potential
modifiable risk factor.
Although it is generally assumed that obesity and LBP
are associated, the actual path between these conditions
remains controversial [6, 8]. For instance, whereas some
studies have shown that obesity increases LBP prevalence
[9, 10], others have failed to observe any association
between the two [11, 12]. Moreover, in a study that used a
twin sample [10], the positive association between body
mass index (BMI) and LBP found in the total sample
analysis disappeared in monozygotic twins dissimilar in
body weight, suggesting that genetics possibly influence
this relationship.
One of the limitations of the studies investigating the
relationship between obesity and LBP is how obesity has
been assessed. The frequent measure used to classify
obesity in previous studies was BMI [2, 8, 13] which does
not account for the distribution of fat in the body. Although
there is evidence that body fat distribution rather than
absolute total fat is associated with increases in the risk of
diseases such as diabetes and coronary artery disease [14],
most studies [2, 8, 13] have not investigated it. To our
knowledge, only two studies have looked at the relation-
ship between body fat distribution (where the excessive
adipose tissue is stored) and LBP and found higher
prevalence of LBP in women with a predominant central
obesity, measured by waist circumference and waist–hip
ratio [15, 16]. Although familial factors (genetics and early
environment) were not investigated in these studies, the
findings indicate that body fat distribution, in addition to
total fat, should be considered when analyzing the obesity–
LBP relationship.
In this current study, we aim to investigate the rela-
tionship between chronic LBP and different measures of
obesity that account for body fat distribution in female
twins. Previous evidence has indicated that women are
more likely to report back pain [5, 17], seek medical care
more frequently [18], and suffer from pain for longer
periods [17] than men. It is likely that women represent a
specific subgroup of patients with LBP and deserves spe-
cial attention particularly when investigating factors such
as body fat distribution. By performing a within-pair twin
case–control analysis (where one twin has chronic LBP
while the co-twin does not), we are able to control for
possible genetic and early shared environmental effects on
the obesity–LBP relationship.
Methods
Design
Cross-sectional observational study with a within-pair twin
case–control design.
Study sample and data collection
All twins included in this study were registered in the
Murcia Twin Registry (MTR), a population-based twin
registry of adult multiples born between 1940 and 1966 in
the region of Murcia, Southeast Spain. Information
regarding the MTR characteristics and recruitment proce-
dures can be found elsewhere [19]. All registry and data
collection procedures involved in this study were approved
by the Murcia University Ethics Committee, and informed
consent was obtained from all twins.
Assessment of chronic LBP
The main outcome of this study was lifetime prevalence of
chronic LBP with participants being asked the following
question: ‘‘Have you ever suffered from chronic low back
pain?’’, based on the corresponding item from the Spanish
National Health Survey. The Survey defines ‘chronic’ as a
health problem lasting for at least 6 months to screen and
eliminate isolated acute processes. This includes seasonal
or recurrent episodes. Participants answering ‘‘yes’’ to this
question were categorized as having a history of chronic
LBP.
Measures of obesity-related measures
Self-reported measures of weight and height were obtained
for 38 % of the sample (430 participants). For the other
62 % of the sample (698 participants), standardized
anthropometric measurements were obtained on partici-
pants by a blinded research assistant for weight, height,
waist circumference and percent body fat. BMI was cal-
culated by dividing the individuals’ body weight in kilo-
grams by the square of their height in meters. Percentage of
body fat was measured by bioelectrical impedance using
TANITA BC-420 MA (Tanita Corporation of America,
USA) equipment. A single new and calibrated device was
used during the whole study. Subjects were instructed to
fast and not practise physical exercise during the previous
4 h, refrain from drinking alcoholic beverages during the
last 24 h, and urinate closely prior to the appointment.
Waist circumference was measured at the narrowest torso
circumference or, alternatively, at the midpoint between
the inferior border of the ribcage and the superior aspect of
Eur Spine J (2016) 25:1188–1195 1189
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the iliac crest using an inelastic measuring tape. Hip cir-
cumference was measured at the widest point or, alterna-
tively, over the buttocks’’. Waist–hip ratio (WHR) was
calculated as the ratio between their respective
components.
Statistical analysis
The analysis was conducted in three stages: (i) total sample
analysis; (ii) within-pair case–control analysis for
monozygotic (MZ) and dizygotic (DZ) twins together; (iii)
within-pair case–control analysis separated by DZ (iii.a)
and MZ (iii.b) (Fig. 1). BMI, percent body fat, waist cir-
cumference and waist-hip ratio were classified in four
categories according to percentile distributions of the data
(i.e., category one B25th lowest percentile; 25th per-
centile\ category two B 50th percentile; 50th\ category
three B 75th percentile; category four[ 75th percentile).
The specific cut-off points used to define the quartiles for
obesity-related measures are defined in Table 1.
Potential confounders for the total sample analysis
included age, engagement in leisure physical activity,
engagement in daily physical activity (work and domestic
related) and smoking. The same confounders were inves-
tigated for the within-pair twin case–control analyses,
except age. Leisure physical activity was dichotomised into
low/no physical activity engagement in recreational phys-
ical activity (mainly sedentary) or moderate/vigorous
physical activity engagement (regular physical activity or
training several times a week/month, ex: jogging, swim-
ming, cycling). Daily physical activity was dichotomised
into low/no engagement in work-related physical activity
(mainly sitting or light physical efforts) or moderate/vig-
orous physical activity engagement (doing tasks that
require a strong physical effort). Smoking was dichot-
omized as ex/never smoker or current smoker. We included
confounders in the multivariate logistic regression models
if p values for associations in univariate models were\0.2.
Total sample analysis
For the total sample analysis, we investigated the associ-
ation between obesity-related measures (BMI, percent
body fat, waist circumference and waist–hip ratio) and
lifetime prevalence of chronic LBP using separate
multivariate unconditional regression models for each
obesity measure. All participants were included and twins
were analyzed as individuals rather than pairs.
Within-pair twin case–control analyses
To control for the effect of genetics and early shared
environment on a possible association between obesity-
related measures and the lifetime prevalence of chronic
LBP, we performed a subsequent within-pair twin case–
control analysis on all complete and discordant pairs for
LBP status (one twin reported chronic LBP while the other
did not) using conditional logistic regression. In addition,
separated analyses were conducted for DZ and MZ twin
pairs. Theoretically, when the magnitude of the association
between two variables (i.e., BMI and LBP) increases
sequentially from the total sample analysis (no adjustment
for genetics or early shared environment) to a DZ within-
pair case–control analysis (adjustment for early shared
environment and approximately 50 % of genetics occurs)
and then to a MZ within-pair case–control analysis (ad-
justment for early shared environment and approximately
100 % of genetics), the relationship between the two
variables is more direct and possibly more consistent with a
direct causal path [20].
We set p\ 0.05 as our level of significance for the
estimates of association in the multivariate models and
presented estimates as odds ratios (OR) and 95 % confi-
dence intervals (CI). OR represents the odds of having
chronic LBP per quartile step. Data analyses were per-
formed using STATA statistical software (version 12.0).
Results
Sample characteristics
Data on lifetime prevalence of chronic LBP for the total
sample of 1128 females was estimated as 41.3 % (95 % CI
38.4–44.2) with the prevalence for MZ and DZ estimated
as 43.1 % (95 % CI 38.3–47.9) and 40.3 % (95 % CI
36.7–43.9), respectively. Among all twins, the mean age
was 54 years with 64 % of the twins being DZ (Table 2).
Results for the obesity-related measures for twins with and
without chronic LBP are described in Table 3.
(i)Total sample analysis
All participants
irrespective of 
concordance status for 
chronic LBP 
(ii)Within-pair case-
control analysis
MZ and DZ complete 
pairs and discordant 
for chronic LBP  
(iii.a)DZ within-pair 
case-control analysis  
DZ complete pairs 
and discordant for 
chronic LBP  
(iii.b)MZ within-pair 
case-control analysis 
MZ complete pairs 
and discordant for 
chronic LBP  
Fig. 1 Statistical analysis schema. LBP low back pain, MZ monozygotic twins, DZ dizygotic twins
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Table 1 Cut-off points used for
the obesity-related measures
Obesity related measures 10 Quartile 20 Quartile 30 Quartile 40 Quartile
Body mass index (kg/m2) B23.71 [23.71 to B26.40 [26.40 to B30.11 [30.11
Percent body fat (%) B29.64 [29.64 to B34.93 [34.93 to B39.55 [39.55
Waist circumference (cm) B76 [76 to B84 [84 to B93 [93
Waist-hip ratio B0.78 [0.78 to B0.84 [0.84 to B0.89 [0.89
Table 2 Study sample
characteristics of
anthropometric data and
lifestyle factors
Variables LBP absent LBP present Total
Mean (SD) or % n Mean (SD) or % n Mean (SD) or % n
Age (years) 53.23(7.38) 662 53.59 (7.38) 466 53.38 (7.38) 1128
Height (m) 1.57 (0.07) 662 1.57 (0.07) 466 1.57 (0.07) 1128
Weight (kg) 66.19 (11.24) 662 67.79 (12.39) 466 66.85 (11.75) 1128
Smoking habitsa 38.75 % 255 42.12 % 195 40.14 % 450
Daily physical activityb 15.58 % 103 11.83 % 55 14.03 % 158
Leisure physical activityb 53.34 % 351 43.44 % 202 49.24 % 553
DZ twins 59.69 % 428 40.31 % 289 63.56 % 717
MZ twins 56.93 % 234 43.07 % 177 36.44 % 411
LBP low back pain, DZ dizygotic, MZ monozygotic, BMI body mass index, SD standard deviation,
n number of participants
a Percentage who smoked
b Percentage engaged in physical activity
Table 3 Study sample
characteristics of obesity-related
measures for the total sample
and cases and controls within a
twin pair
Variables LBP absent LBP present Total
Mean (SD) or % n Mean (SD) or % n Mean (SD) or % n
Body mass index
Total sample 26.81 (4.59) 662 27.68 (5.23) 466 27.17 (4.88) 1128
MZ and DZ pairs 27.42 (4.88) 155 27.68 (5.65) 155 27.55 (5.28) 310
DZ pairs 27.75 (4.83) 77 28.48 (5.42) 77 28.11 (5.13) 154
MZ pairs 27.09 (4.95) 78 26.90 (5.80) 78 26.99 (5.38) 156
Body fat (%)
Total sample 34.14 (7.03) 374 34.93 (7.60) 313 34.50 (7.30) 687
MZ and DZ pairs 34.85 (7.40) 128 35.71 (7.18) 128 35.28 (7.29) 256
DZ pairs 35.14 (7.14) 65 36.77 (7.06) 65 35.95 (7.12) 130
MZ pairs 34.55(7.71) 63 34.62 (7.20) 63 34.58 (7.43) 126
Waist circumference (cm)
Total Sample 84.64 (11.94) 378 85.40 (12.50) 316 84.99 (12.20) 694
MZ and DZ pairs 85.79 (11.25) 132 86.42 (12.59) 132 86.10 (12.05) 264
DZ pairs 86.92 (10.85) 67 88.98 (12.46) 67 87.95 (11.69) 134
MZ pairs 84.63 (12.15) 65 83.77 (12.27) 65 84.20 (12.17) 130
Waist-hip ratio
Total Sample 0.85 (0.08) 371 0.85 (0.08) 311 0.85 (0.08) 682
MZ and DZ pairs 0.85 (0.07) 132 0.85 (0.08) 132 0.85 (0.08) 264
DZ pairs 0.86 (0.08) 67 0.87 (0.08) 67 0.86 (0.08) 134
MZ pairs 0.85 (0.07) 65 0.84 (0.07) 65 0.84 (0.07) 130
LBP low back pain, SD standard deviation, n number of participants, MZ monozygotic, DZ dizygotic
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BMI
BMI (OR 1.13; 95 % CI 1.02–1.26) was weakly associated
with lifetime prevalence of chronic LBP in the total sample
analysis but no association was found between BMI and
chronic LBP in any of the within-pair twin case–control
analyses (Table 4).
Percent body fat
Percent body fat (OR 1.15; 95 % CI 1.01–1.32; p = 0.05)
was weakly associated with lifetime prevalence of chronic
LBP but no association was identified in any of the within-
pair case–control analyses.
Waist circumference
No association was found between waist circumference and
lifetime prevalence of chronic LBP for the total sample or
the within-pair case–control analyses.
Waist-hip ratio
No association was found between waist–hip ratio and
lifetime prevalence of chronic LBP for the total sample
analysis. Waist–hip ratio was associated with chronic LBP
in the within-pair case–control analysis with MZ and DZ
twins included (OR 0.67; 95 % CI 0.47–0.94). When the
analyses were performed separately for zygosity, a stronger
association was found for DZ twins (OR 0.59; 95 % CI
0.35–0.98) and the association disappeared when the
analysis was conducted for MZ twins (OR 0.77; 95 % CI
0.48–1.25).
Discussion
To our knowledge, this is the first study investigating the
obesity–LBP relationship in females that considered not
only traditional measures of obesity such as BMI but also
measures of body fat distribution and explored the effects
of genetics and early shared environment. We found that
lifetime prevalence of chronic LBP was weakly associated
with measures of obesity. However, the association was no
longer present after the full adjustment for genetics and
early shared environmental factors in MZ twins dissimilar
for LBP status. These results suggest that a causal direct
link between obesity and chronic LBP is unlikely.
BMI and percent body fat
Our results demonstrated that lifetime prevalence of
chronic LBP was associated with BMI and percent body fat
when the total sample of twins (with no adjustment for
genetics or early shared environment among twins) was
used. The association was small (OR 1.1 and OR 1.2 for
BMI and percent body fat, respectively), but in agreement
with previous cross-sectional studies [21–23].
Obesity and LBP are complex traits resulting from
multiple interactions between genetic and environmental
factors. For example, 35–60 % of the body fat [24], and
67 % of LBP [25] variances can be accounted for by the
transmission of genetic and familial environmental factors.
Consequently, the true extent of the effect of obesity on
LBP is difficult to estimate, and for a clear and more direct
identification of obesity–LBP relationship other factors,
including familial factors, should be considered.
We found that after the adjustment for familial factors,
using the within-pair twin case–control design, the signif-
icant association between chronic LBP and both BMI and
percent body fat did not persist. This pattern of attenuated
associations after controlling for familial factors is in
agreement with the previous twin studies that investigated
the obesity and LBP relationship using a within-pair twin
Table 4 Total sample analysis and within-pair twin case–control
analysis for chronic low back pain
Multivariate models OR (95 % CI) p value n
Body mass index (kg/m2)
Total samplea 1.13 (1.02–1.26) 0.026* 1123
MZ and DZ pairsa 1.12 (0.83–1.51) 0.449 310
DZ pairsa 1.04 (0.69–1.58) 0.842 154
MZ pairs 1.19 (0.78–1.83) 0.444 156
Percent body fat (%)
Total sampleb 1.15 (1.01–1.32) 0.047* 682
MZ and DZ pairs 1.27 (0.93–1.75) 0.138 256
DZ pairsa 1.41 (0.88–2.26) 0.149 130
MZ pairs 1.23 (0.78–1.94) 0.369 126
Waist circumference (cm)
Total sampleb 1.06 (0.93–1.22) 0.378 689
MZ and DZ pairs 0.84 (0.62–1.15) 0.277 264
DZ pairsa 0.83 (0.54–1.26) 0.374 134
MZ pairs 0.89 (0.56–1.42) 0.638 130
Waist-hip ratio
Total sampleb 1.02 (0.89–1.17) 0.779 677
MZ and DZ pairs 0.67 (0.47–0.94) 0.022* 264
DZ pairsa 0.59 (0.35–0.98) 0.040* 134
MZ pairs 0.77 (0.48–1.25) 0.289 130
OR odds ratio, CI confidence interval, MZ monozygotic, DZ dizy-
gotic, n number of participants in each analytical step
* Statistically significant p\ 0.05
a Adjusted for leisure physical activity
b Adjusted for smoking and leisure physical activity
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case–control design [10, 21]. It suggests that genetics and
common shared environment facts play an important role
when measures such as BMI and percent body fat are
investigated as part of the obesity–LBP relationship.
Waist circumference and waist–hip ratio
Our results did not reveal any association between waist
circumference and lifetime prevalence of chronic LBP for
the total sample analysis or for any of the within-pair case–
control analyses. In addition, no association was found
between waist–hip ratio and lifetime prevalence of chronic
LBP for the total sample analysis. However, the within-pair
twin case–control analysis, with both MZ and DZ twins
included, showed a significant inverse relationship between
waist–hip ratio and chronic LBP (OR 0.7; 95 % CI
0.5–0.9), meaning that women with greater waist–hip ratios
had lower estimates of prevalence of chronic LBP.
When we sequentially separated the analysis for DZ and
then MZ twins pairs, even though the pattern of association
remained the same (inverse relationship between waist–hip
ratio and chronic LBP), the association was significant only
in DZ twins (OR 0.6; 95 % CI 0.4–1.0), disappearing after
the full adjustment for genetic factors in the MZ twins (OR
0.8; 95 % CI 0.5–1.3). The pattern of a significant rela-
tionship being observed in the within-pair twin case–con-
trol analysis and in the within-pair twin DZ only case–
control analysis but not in the total sample analysis indi-
cates that when genetics and early shared environment
among twins are considered, a relationship between waist–
hip ratio and chronic LBP is stronger and possibly more
direct. This association is attenuated and was not statisti-
cally significant when only MZ twins are analyzed (OR
0.8; early shared environment and genetic component are
fully controlled for) as opposed to DZ twins only (OR 0.6;
early shared environment fully controlled for but genetic
component only partially controlled for). Although there is
not a clear explanation for this effect, this finding could
point to the possibility that when a full adjustment for
genetics and early environment is implemented, the sig-
nificant relationship initially observed in DZ twins disap-
pears. Thus, genetics could be responsible for the possible
relationship between waist–hip ratio and chronic LBP.
The direction of the relationship between waist–hip ratio
and chronic LBP were somewhat unexpected. Our findings
suggest that chronic LBP prevalence is smaller in women
with a higher waist–hip ratio. Thus, those individuals with
greater hip circumferences (accumulation of fat and cor-
responding weight around the hip bones) were more likely
to have chronic LBP. Our results are in agreement with a
population-based cross-sectional study in middle-aged
women, which showed that even after the adjustment of
many possible confounder factors such as work-related and
physical activity, high waist-to-hip ratio was still inversely
associated with the risk of severe LBP [26]. However, this
study did not control for genetics factors and early shared
environment. These findings are in contrast to other earlier
studies that used samples of women from the general
population where greater levels of central obesity were
associated with LBP [15, 16]. From a biomechanical per-
spective, it is plausible that greater fat mass around the
waist area loads the spine through gravity. However, it is
also mechanically plausible that greater hip to waist mass
could potentially unbalance the forces around the spine,
leading to lumbar–pelvic instability and LBP [27]. It is
important to note that the assessment of waist–hip ratio not
only incorporates the distribution of fat but also is a
reflection of bony anatomical features such as the shape of
the pelvis. However, it is possible that the results found in
the intermediate analytical steps are a result of genetics
confounding the association between waist–hip ratio and
chronic LBP. It is important to note that this finding was
only present in the intermediate analytical steps (MZ/DZ
analysis and DZ analysis) where DZ pairs are included, and
consequently 50 % of genetics are not controlled for.
Limitations
We acknowledge several limitations in our study design.
Firstly this was a cross-sectional analysis, which limits
possible insights on a causation path between the variables
of interest. Secondly, the measure of chronic LBP used in
this study was somewhat simple and did not include
additional assessments of the severity, frequency, as well
as disability levels associated with LBP. This assessment of
LBP might have influenced the results as patients’ under-
standing of what constitutes chronic LBP and degrees or
patterns of chronicity may vary. Thirdly, the accuracy of
BMI data could have been affected by the combination of
self-reported with a direct measure of weight and height
used to calculate BMI given that self-reported assessment
methods seem to underestimate weight and overestimate
height values [28]. In our sample, the difference between
the subgroups for BMI data, measured (27.53 kg/m2) and
self-reported (26.58 kg/m2), was 0.96 kg/m2. We have
tested the association between LBP and both subgroups for
BMI for all analytical steps, and the difference in OR found
were very small (=OR\ 0.2) and clinically not signifi-
cant. Therefore, we believe that the combination of self-
reported with a direct measure of weight and height have
little or no effect in our results.
Also, in spite of being a practical and widely used
assessment method, uncertainty has been raised regarding
the validity and reliability of bioelectrical impedance
measurements for estimation of body fat [29]. However, we
should take into account the homogeneous character of our
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sample and the measurement conditions, and the fact that
the objective of this study is not to determine the exact
value of body fat percentage but analyzing its possible
association with LBP. Consequently, we believe that the
method of body fat measurement does not have a relevant
effect on our results and conclusions. Lastly, we recognize
that the smaller sample size in the case–control analyses
reduced the power required to identify a relationship
between obesity-related measures and chronic LBP, if in
fact, the relationship exists. Therefore, we cannot exclude
that a much larger twin sample would show a significant
result. Although smaller samples and larger confidence
intervals observed in the case–control analyses could add
uncertainty to the results of our study, the imprecision of
the data is unlikely to be the explanation for this finding.
Firstly, the average values between LBP and non LBP
groups are very small for all variables in all analysis steps.
Furthermore, the magnitude of the ORs for the significant
predictors in the total sample (BMI and percent body fat) is
still similar to the all within-pair twin case–control analy-
ses, which points to the fact that the association between
obesity-related measures and chronic LBP in fact was weak
and non-reliable when twins were considered as individu-
als. Secondly, according to a systematic review recently
published, the reduced association between LBP and obe-
sity seems to be consistent across studies when genetics
and the environment factors are considered [30]. Pooled
results of two MZ case–control studies with greater sample
sizes than ours, 442 [10] and 413 [21] pairs, has shown no
association between obesity and LBP (OR 1.4; 95 % CI
0.8–2.3) [30]. Notwithstanding, this study represents a step
forward in the investigation of the relationship between
obesity and chronic LBP relationship because we used a
comprehensive assessment of obesity that accounts for
body fat distribution and employed a within-pair case–
control design to allow for more direct and precise esti-
mates of obesity–LBP relationship.
In summary, BMI, percent of fat mass and greater
depositions of fat and mass around the hips are associated
with increases in chronic LBP prevalence in women.
However, these associations are small and disappear with
the full adjustment for genetics and early shared environ-
ment effects. Therefore, our results do not support a causal
direct relationship between obesity and chronic LBP. We
advocate that the results observed in this study should be
tested in the future in a longitudinal twin research design.
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CHAPTER FOUR 
Obesity does not increase the risk of chronic low back pain when genetics is 
considered. A prospective study of Spanish adult twins. 
Reprinted from: The Spine Journal, Dario, A.B., et al., Obesity does not increase the risk of 
chronic low back pain when genetics is considered. A prospective study of Spanish adult twins, 
2016, with permission from Elsevier.  
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SUPPLEMENTARY ANALYSIS 
Title: Obesity-related measures do not seem to be determinants for low back pain: Insights from 
Australian identical twins.  
Background  
Recent evidence suggests the association between obesity and low back pain (LBP) is not 
consistent across cultures [1]. In some countries, obese individuals are over three times more 
likely to experience LBP (e.g. Finland: OR 3.33; 95 % CI 2.09 to 5.30), while in other countries 
the association between obesity and LBP is weak (e.g. Spain: OR 1.56; 95 % CI 1.03 to 2.35), or 
absent (e.g. China: OR 1.00; 95 % CI 0.65 to 1.55) [1]. These findings suggest that the obesity-
LBP relationship appears to be dependent on the underlying genetic make-up of the population 
investigated and the environmental variation at play. Therefore, to get a clearer understanding of 
whether obesity is a risk factor for LBP the influence of genetic and environmental factors 
should be taken into account. 
In Chapters Three and Four of this thesis, the association between obesity-related 
measures and LBP were investigated in twins. The twin design represents a unique method to 
overcome genetic and environmental confounding, in particularly when investigating pairs of 
identical twins. Identical twins, also called monozygotic twins (MZ), are considered nearly 
genetically identical - “a natural clone” - as they are from the same fertilized ovum. Moreover, 
MZ twins tend to be exposed to a common environment (e.g. diet, education) until early 
adulthood [2]. Consequently, the use of identical twin pairs discordant for LBP (co-twin design) 
represents a robust approach when investigating whether obesity-related measures are risk 
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factors for LBP, as this method allows us to control for a number of important confounders (e.g. 
genetics and early shared environment).  
The results of the cross-sectional (Chapter Three) and longitudinal (Chapter Four) 
analyses, which utilized a co-twin design, indicated that obesity-related measures are unlikely to 
be risk factors for LBP. However, both studies used a sample of Spanish twins from Murcia, a 
Mediterranean region with high prevalence of obesity [3], and therefore little variance in obesity-
related measures, which may compromise the generalizability of these findings to other 
populations. Then, to further explore the relationship between obesity-related measures and LBP, 
we used a sample of twins from Australia to compare the concordance rates of obesity-related 
measures within MZ twin pairs discordant or concordant for LBP. We hypothesized that the 
degree of concordance in obesity-related measures would not differ considerably between twin 
pairs discordant or concordant for LBP. These findings would indicate that obesity-related 
measures are unlikely to be risk factors for LBP, consistent with the results of the previous 
chapters.  
 
Methods  
Design: Cross-sectional observational study.  
Study sample and data collection: The study sample comprised adult MZ twin pairs from 
Australia, ranging from 18 and 72 years old. Data were collected on the 22nd March 2015, during 
the Twins Festival in Melbourne. This festival was a national event organised by the Australian 
Twin Registry attracting over 2000 Australian twins (http://www.twinsfestival.com.au/). During 
the event, twins were informed about the objectives of the study. Twins interested in 
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participating signed the consent form and provided self-reported information about their 
demographics and medical history. To collect obesity-related measures, participants were invited 
to attend a physical examination. The University of Sydney and Australia Twin Registry ethics 
committees approved all data collection procedures involved in this study. 
Anthropometric measures. Standardized anthropometric measures such as height, weight, 
percentage of fat mass, and waist and hip circumference were assessed by trained researchers. 
Percentage of fat mass was measured by bioelectrical impedance using TANITA equipment 
(model TISC330S, Tanita Corporation of America, USA). Waist circumference was measured at 
the point on the torso where the circumference would be the smallest or at the midpoint between 
the inferior border of the ribcage and the superior aspect of the iliac crest using an inelastic 
measuring tape. Hip circumference was measured either at the widest point or over the buttocks. 
Waist-hip ratio was calculated from the respective components. Body mass index (BMI) was 
calculated by dividing the individuals’ body weight in kilograms by the square of their height in 
meters. 
Assessment of LBP. Data on the presence of LBP within the past four weeks was self-reported 
and obtain from the following question: “In the past 4 weeks, have you had pain in your low 
back? Please do not report pain from feverish illness or menstruation”. This question was derived 
from a standardized definition of LBP for the use in epidemiological studies [4].  
Statistical analysis. We used descriptive statistics to present the characteristics of the cohort, 
including demographic characteristics, LBP prevalence, and anthropometric measures. For each 
anthropometric measure, we calculated the differences within-pair and the intraclass correlation 
coefficients (ICC) [95% Confidence Intervals (CI)] for the total sample and subgroups according 
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to the concordance (or discordance) of LBP status. STATA 13 software was used to perform the 
analysis.  
 
Results  
Sample characteristics  
A total of 31 twin pairs had demographic and anthropometric data available and were 
included in this analysis (Table 1). The mean age of twins was 43.4 [range: 19 to 73; standard 
deviation (SD): 16.1] years, and the majority of the sample was composed of females (84%). 
Twins, on average, were overweight (BMI: 26.7 kg/m2), and 51% reported having LBP in the 
last four weeks. When analyzing all twin pairs regardless of concordance (or discordance) for 
LBP, we observed high intrapair correlations for most of the obesity-related measures with 
coefficients greater than 0.85.  The only obesity-related measures that presented a fair (ICC< 0.6) 
intrapair correlation was waist-hip ratio (ICC: 0.57, 95% CI 0.27 to 0.78) (Table 2).  
Table 1 Study sample characteristics of anthropometric measures. 
Variables Mean (SD) or % Range n 
Age (years) 43.4 (16.1) 19 to 73 62 
Female 83.9 - 62 
Height (m) 1.66 1.50 to 1.86  
Weight (kg) 73.1 (16.4) 44 to 119 62 
Body mass index (m/h2) 26.7 (5.7) 18.4 to 45.9 62 
% Fat mass 31.7 (9.6) 9.6 to 49.7 62 
% Lean mass 65.0 (9.0) 47.8 to 86.0 62 
Waist circumference 91.7 (15.6) 68 to 144 56 
Waist-hip ratio 0.89 (0.1) 0.75 to 1.09 56 
LBP: low back pain; SD: standard deviation; n: number of participants.  
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Obesity-related measures and LBP concordance within twin pairs   
The majority of twin pairs (77.4%) reported being concordant for LBP status in the past 
four weeks: 12 (38.7%) twin pairs did not have LBP while 12 (38.7%) twin pairs had LBP 
(Table 2). Only 7 (22.6%) pairs reported being discordant for LBP status. When observing the 
mean difference for obesity-related measures within twin pairs, the differences within twin pairs 
discordant for LBP were not greater than the differences within twin pairs concordant for LBP. 
For example, among twin pairs discordant for LBP the mean difference for BMI within the pairs 
was 0.3 m/h2 compared to 3.5 m/h2 in twin pairs concordant for not having LBP. Similar results 
were found for weight, percentage of fat mass, waist circumference and waist-hip ratio (Table 2). 
A similar pattern was found for the intrapair correlations. For most obesity-related 
measures, the intrapair correlations were similar across twin pairs concordant and discordant for 
LBP. For instance, intrapair correlations ranged from 0.73 to 0.93 for weight, BMI and % fat 
mass, irrespective of the concordance for LBP. However, twin pairs discordant for LBP had a 
lower concordance for their waist circumference (ICC = 0.36) when compared to twin pairs 
concordant for having (ICC = 0.84) or not having LBP (ICC = 0.87). 
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Table 2. Obesity-related measures of intrapair concordance in monozygotic twins for the total 
sample and according to low back pain status.  
LBP: low back pain; BMI: body mass index; r: correlation within-pair; ICC: 
intraclass correlation coefficients; CI: Confidence interval.  
Obesity-related measures 
Within-pair 
difference  
Correlation N pairs 
ICC (95% CI) 
Weight (kg) 
  Total sample 6.6 0.86 (0.72 to 0.93) 31 
    Concordant - no LBP 9.3 0.89 (0.66 to 0.97) 12 
    Concordant - LBP  4.6 0.73 (0.28 to 0.92) 11 
    Discordant - LBP 5.0 0.93 (0.68 to 0.99) 7 
BMI (m/h2) 
 Total sample 2.3 0.85 (0.71 to 0.92) 31 
    Concordant - no LBP 3.5 0.91 (0.74 to 0.97) 12 
    Concordant - LBP  1.6 0.75 (0.34 to 0.93) 11 
    Discordant - LBP 0.3 0.87 (0.49 to 0.98)  7 
% Fat mass 
 Total sample 3.6 0.90 (0.80 to 0.95) 31 
    Concordant - no LBP 5.1 0.93 (0.77 to 0.98) 12 
    Concordant - LBP  3.2 0.82 (0.49 to 0.95) 11 
    Discordant - LBP 0.0 0.89 (0.53 to 0.98) 7 
Waist Circumference (cm) 
 Total sample 6.2 0.86 (0.72 to 0.93) 28 
    Concordant - no LBP 7.8 0.84 (0.51 to 0.96) 10 
    Concordant - LBP  7.0 0.87 (0.60 to 0.96) 11 
    Discordant - LBP 2.8 0.36 (-0.47 to 0.87) 7 
Waist-hip ratio 
 Total sample 0.05 0.57 (0.27 to 0.78) 28 
    Concordant - no LBP 0.05 0.83 (0.48 to 0.95) 10 
    Concordant - LBP  0.04 0.28 (-0.38 to 0.71) 11 
    Discordant - LBP 0.03 0.93 (0.66 to 0.99) 6 
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Discussion 
Our data from Australian twins showed no evidence of major dissimilarities in those 
twins discordant for LBP for any of the obesity-related measures. Interestingly, within-twin pair 
differences in measures of obesity were often smaller in twin pairs discordant for LBP. Although 
there are some limitations in this supplementary analysis, such as the small sample size, the 
results nevertheless question the hypothesis that obesity is a strong risk factor for LBP, 
consistent with the previous findings presented in Chapters Two, Three, and Four [5, 6]. This 
supplementary analysis also provided evidence of close agreement for both obesity-related 
measures and LBP within MZ twin pairs. Twenty-four (77%) of the 31 pairs were concordant for 
LBP status, and, irrespective of the concordance status for LBP, the ICCs for most obesity-
related measures were higher than 0.7. These findings are not surprising as they are consistent 
with other studies in suggesting that genetic factors play a significant role in obesity and in 
LBP status [7-10].  
The high concordance rates in both traits also reinforce the possibility of shared familial 
determinants (both genetic and environmental) underlying the occurrence of obesity and LBP. 
Although not tested in this thesis, it is likely that there might be some overlap of familial 
determinants that are common to both obesity and LBP. Using a sample of 1452 females twin 
pairs (756 MZ and 696 DZ pairs) from England, the effects of share common genetics and 
environmental components in the obesity-LBP relationship were quantified [11]. The English 
study reported a significant, but modest, additive genetic correlation [r 0.205 (± 0.015)] and 
environmental correlation [r 0.101 (± 0.064)] for the association between obesity (assessed by 
BMI) and LBP.  
In summary, the findings from this supplementary analysis, using a small sample of 
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Australian twins, reinforces the familial resemblance of both obesity-related measures and LBP 
status. Furthermore, it demonstrated that the concordance for obesity-related measures does not 
differ according to the presence or absence of LBP. These results further question a direct causal 
path between obesity-related measures and LBP, when the influences of genetic and shared 
environmental factors are considered.  
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CHAPTER FIVE 
Mapping the association between back pain and type 2 diabetes: 
A cross-sectional and longitudinal study of adult Spanish twins 
This Chapter has been under review in PLOS ONE since 13  October 2016, and it is in the format 
required by this journal. 
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Abstract 1 
2 
Background: Back pain and type 2 diabetes often co-occur, resulting in greater impact on 3 
people’s health and complexity in their care. Plausible causal mechanisms for this association 4 
have been proposed, yet the nature of the link remains unclear. We therefore explored the 5 
direction of the association between type 2 diabetes and chronic back pain in twins, controlling 6 
for genetics and early environmental confounding.  7 
8 
Methods: 2,096 and 1,098 twins were included in the cross-sectional and longitudinal analyses, 9 
respectively. Any or severe (≥ 9) low back pain (LBP), neck pain (NP), and spinal pain 10 
(concurrent LBP and NP) and type 2 diabetes were investigated. Sequential analyses were 11 
performed using logistic regression. Firstly, twins were analysed unpaired (adjusted age and 12 
gender): total sample analyses. Then, to control for genetic and shared environmental factors, a 13 
co-twin case-control analysis was performed including monozygotic and dizygotic twin pairs 14 
discordant for back pain (cross-sectional only).  15 
16 
Results: In the cross-sectional total sample analyses, type 2 diabetes was associated with chronic 17 
spinal pain (OR 1.61; 95%CI 1.12 to 2.31), severe chronic spinal pain (OR 3.33; 95%CI 1.47 to 18 
7.53), chronic NP (OR 1.37; 95%CI 1.01 to 1.85), severe chronic NP (OR 2.28; 95%CI 1.24 to 19 
4.21), and severe chronic LBP (OR 1.63; 95%CI 1.00 to 2.64). After further adjustment for 20 
genetic and shared environmental factors, none of the associations remained significant. The 21 
longitudinal analyses indicated that the presence of type 2 diabetes did not increase the risk of 22 
future back pain, or vice-versa, after two to four years.  23 
24 
Conclusions: Chronic back pain (spinal pain, NP, or LBP) was associated with the prevalence of 25 
type 2 diabetes. Associations are stronger for severe cases of pain. Future research should 26 
investigate the temporal relationships between these conditions with longer follow up in twins. 27 
28 
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Introduction 1 
Diabetes, low back pain (LBP) and neck pain (NP) are all recognized major public health 2 
problems (1-3). They are common and costly conditions, ranking among the top seven causes of 3 
years lived with disability worldwide (1). Recent studies have reported that diabetes commonly 4 
coexists with LBP and NP (4-7). The prevalence of LBP among people with diabetes is twice as 5 
high as among age- and gender-matched controls (8). Importantly, patients with concurrent 6 
diabetes and LBP have more frequent recurrence of pain, higher levels of LBP-specific 7 
disability, and poorer general health than those with LBP in isolation (6, 9). Furthermore, those 8 
presenting with both conditions are twice as likely to be admitted to hospital [OR: 2.02; 95% 9 
confidence interval (CI): 1.69 to 2.40] and to have surgery for cervical or lumbar disc disease, 10 
which incurs significant health care expenditure (7, 9-11). 11 
12 
Recent evidence suggests that diabetes and back pain, including LBP, NP and spinal pain 13 
(concurrent LBP and NP), not only co-exist, but may in fact be bi-directionally linked. The 14 
hyperglycemia and altered fat metabolism commonly present in diabetes have been linked to 15 
pathoanatomical changes of the spine, such as early degeneration of vertebrae, cartilage, and 16 
intervertebral discs (12-16). These changes are a frequent finding in osteoarthritic spinal joints 17 
and have been associated with pain (17-20). Conversely, chronic pain is well known to have an 18 
adverse impact on health behaviours such as physical activity and diet, and these lifestyle 19 
choices may induce type 2 diabetes (21-23). 20 
21 
Apart from a possible bi-directional relationship between diabetes and back pain, it is also 22 
plausible that these health conditions coexist due to common risk factors, such as genetic 23 
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influences, on their pathogeneses (24). Family-based studies have consistently suggested the 1 
presence of a major genetic component underlying the variation (heritability) of LBP (52%; 95% 2 
CI 33 to 72%), NP (48%; 95% CI 29 to 67%) and type 2 diabetes (72%; 95% CI 61 to 78%) (25, 3 
26). Therefore, genetics should be taken into account to obtain more precise estimates when 4 
investigating a possible direct path between back pain and diabetes. 5 
6 
Considering that the global population is ageing and becoming more obese, a future increase in 7 
the burden of diabetes and back pain is likely to occur, as these conditions are commonly 8 
observed in the older and obese populations (27-29). Understanding potential causal risk factors 9 
for diabetes and back pain is therefore paramount for optimizing treatment and prevention of 10 
these conditions. Thus, we explored the bi-directional association, in terms of precision and 11 
magnitude, between type 2 diabetes and chronic back pain [chronic LBP, chronic NP, and 12 
chronic spinal pain] using a Spanish twin sample.  The use of twin pairs discordant for a health 13 
condition, in this case back pain, allows the influence of critical potential confounders such as 14 
genetic and early environmental factors to be controlled. 15 
16 
Method 17 
Study design: Cross-sectional and longitudinal observational study with a co-twin case-control 18 
design. 19 
20 
Participants and data collection: The study sample comprised adult twins from the Murcia Twin 21 
Registry (MTR) in Spain who were born between 1940 and 1966 in the region of Murcia. For the 22 
present study, twins recruited by the MTR in the second data wave (baseline: 2009 to 2011) and 23 
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third data wave (follow-up: 2013) who provided information on diabetes and back pain were 1 
included. Data were collected face-to-face or via telephone interviews conducted by research 2 
assistants who were blinded to the predictors and outcomes of the study. Recruitment and data 3 
collection procedures for the MTR were approved by the University of Murcia ethics committee 4 
(30). 5 
6 
Zygosity evaluation: Twin zygosity was assessed by DNA in 338 pairs and by a 12-item 7 
questionnaire in the remainder of the sample.  The questionnaire, which identifies the degree of 8 
similarity among twin pairs, is in agreement with DNA testing in approximately 96% of cases 9 
(30). 10 
11 
Assessment of LBP, NP, and spinal pain: Information on chronic LBP and chronic NP was 12 
drawn from self-reported responses derived from the Spanish National Health Survey (31). At 13 
baseline, participants were asked “Have you ever suffered from chronic LBP (or NP)?”, followed 14 
by, in case of an affirmative answer “Has it been diagnosed by a doctor?” The definition of 15 
chronic pain used in the survey was the presence of pain in the lower back or neck area lasting 16 
for six months or longer, including seasonal or recurrent episodes. Participants were fully 17 
apprised of this definition during the process of data collection. Participants answering “yes” to 18 
either or both the LBP or NP questions were categorized as having chronic LBP alone, chronic 19 
NP alone, or chronic spinal pain (concurrent LBP and NP). At follow-up, participants who 20 
answered positively to the same chronic LBP and chronic NP questions that were administered at 21 
baseline were asked additional questions to gather information on pain intensity: “How intense 22 
was your pain in the last episode (0= no pain at all; 10 = the worst pain ever)?” 23 
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Assessment of type 2 diabetes: Similar to the assessment of back pain, information on diabetes 1 
was assessed using self-reported responses to the Spanish National Health Survey (31). 2 
Participants were asked the following questions “Have you ever suffered diabetes?” and when 3 
the answer was affirmative, “Has it been diagnosed by a doctor?” An additional question was 4 
asked about medication: “Did you take medication for diabetes in the previous month?” Initially, 5 
those who answered “yes” to one or more of these questions were categorized as having diabetes. 6 
This information was then linked to the regional databases of the Murcia Health Council, which 7 
include data about virtually all patients using the public health system in the geographical area of 8 
the MTR. Only participants for whom the diagnosis of type 2 diabetes could be confirmed 9 
(diagnosed by a physician) were considered as cases. Participants with type 1 diabetes or non-10 
confirmed self-reported type 2 diabetes were excluded (0.5% and 1.9% of the total sample, 11 
respectively). 12 
13 
Assessment of covariates: Potential confounders were selected based on plausible associations 14 
with back pain and diabetes, as well as data availability. Variables investigated included age, sex, 15 
body mass index (BMI), engagement in physical activity (work-related and leisure), and smoking 16 
history. To assess engagement in physical activity and smoking history we used categorical self-17 
reported responses to the Spanish National Health Survey (31). BMI was calculated from self-18 
reported height and weight, and used as a continuous variable. For smoking history, participants 19 
were categorized as current smoker or never smoker/ex-smoker. For leisure-time physical 20 
activity, participants were categorized as sedentary (no engagement in recreational physical 21 
activity) or regularly physically active (low/moderate/vigorous physical activity engagement). 22 
For work-related physical activity, participants were categorized as sedentary (low/no 23 
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engagement in work related physical activity such as mainly sitting or light physical efforts) or 1 
as doing tasks that require a strong physical effort (moderate/vigorous physical activity 2 
engagement). 3 
4 
Statistical Analysis: Descriptive analyses were performed on demographic and clinical 5 
characteristics of the cohort at baseline and follow-up. We then investigated the cross-sectional 6 
and longitudinal associations between diabetes and back pain using univariate and multivariable 7 
regression models. To adjust the models for the similarities shared by twins (i.e. to control for 8 
data dependence due to twin sample), we used a robust sandwich estimator (cluster command in 9 
STATA) in the total sample analyses. In the multivariable regression analyses, we adjusted the 10 
total sample models by age and sex to ensure comparability with the co-twin case-control 11 
models. Possible additional confounders (BMI, engagement in physical activity, and smoking 12 
history) were only included in the models when the p-values were <0.2 for the associations with 13 
both the outcome and exposure. Figure 1 describes the statistical analysis schema. 14 
Figure 1. Statistical analysis schema and sample size. The level of adjustment for confounding 15 
factors increases throughout the analytical stages. 16 
17 
Cross-sectional analyses: To explore a possible association between type 2 diabetes and spinal 18 
pain, NP or LBP, we conducted cross-sectional analyses using the baseline data. In addition, with 19 
the availability of data on pain intensity collected at the follow-up assessment (2013), we 20 
investigated the potential association between type 2 diabetes and severe cases of spinal pain (or 21 
NP, or LBP). Participants in the upper quartile of the distribution of the pain intensity variable, 22 
reporting pain equal to or higher than 9/10, were classified as having severe pain. To control for 23 
81
the possible effects of genetic and early shared environmental factors on the relationship between 1 
type 2 diabetes and chronic spinal pain (or NP, or LBP), we conducted a co-twin case-control 2 
analysis. Only complete and discordant twin pairs (i.e. one twin reported chronic spinal pain, 3 
whereas the co-twin did not) for each back pain outcome were included. Theoretically, the co-4 
twin control design enables adjustment of the estimates for a large number of confounding 5 
factors that twins share, including genetics, as monozygotic and dizygotic twin pairs share 6 
approximately 100% and 50% of their genes, respectively. Furthermore, twins tend to be 7 
exposed to a common environment until early adulthood. 8 
9 
Longitudinal analysis: (i) To investigate type 2 diabetes as a risk factor for chronic spinal pain 10 
(or NP, or LBP), twins were included when they did not report chronic spinal pain (or NP, or 11 
LBP) at baseline and had complete data available at both baseline and follow-up. A similar 12 
method was used to investigate whether type 2 diabetes increased the risk of severe cases of 13 
chronic spinal pain (or NP, or LBP) with twins being included only if they did not report severe 14 
spinal pain (or NP, or LBP) at baseline. (ii) To investigate chronic spinal pain (or NP, or LBP) as 15 
risk factors for type 2 diabetes, twins were included when they did not report diabetes at baseline 16 
and had complete data available at both baseline and follow-up.  17 
18 
Results 19 
Sample characteristics 20 
At baseline, a total of 2,096 twins were included in our cross-sectional analysis. The mean age of 21 
twins was 53.6 [standard deviation (SD) 7.3] years, and the majority of the sample was 22 
composed of female twins (55%). On average, twins were overweight (BMI 27.4kg/m2, SD 4.5), 23 
82
with 18.8% reporting engagement in work-related physical activity and 54.2% in leisure-time 1 
physical activity. The prevalence of chronic spinal pain, NP, and LBP was 18.2% (95% CI 16.5 2 
to 19.8), 28.4% (95% CI 26.5 to 30.3), and 32.2% (95% CI 30.2 to 34.2) respectively, while 3 
10.9% (95% CI 9.6 to 12.3) of twins had a confirmed diagnosis of type 2 diabetes (Table 1). 4 
5 
At follow-up, 1613 twins from the original sample had complete data for back pain and type 2 6 
diabetes. The mean age of the twins was 56.7 (SD 7.1) years and their mean BMI was classified 7 
as overweight (BMI 27.2 kg/m2; SD 4.3). The proportion of those engaged in work-related and 8 
leisure-time physical activity were 20.8% and 66.0%, respectively. The prevalence of chronic 9 
spinal pain, NP, and LBP was 14.8% (95% CI 13.1 to 16.6), 24.8% (95% CI 22.8 to 27.0), and 10 
36.8% (95% CI 34.5 to 39.2); with 13% (95% CI 11.4 to 14.7) of twins presenting with type 2 11 
diabetes (Table 1). The proportions of incident cases of chronic spinal pain, NP, and LBP at 12 
follow-up were 9.0% (95% CI 7.5 to 10.6), 14.7% (95% CI 12.7 to 16.8), and 22.3% (95% CI 13 
19.8 to 24.8), respectively. Incident cases of type 2 diabetes comprised 2.4% (95% CI 1.6 to 3.3) 14 
of the twins over two to four years follow-up (Table 1). 15 
[Table 1] 16 
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Table 1 Characteristics of study sample, including anthropometric data, lifestyle factors, and 
type 2 diabetes and back pain status at baseline and follow-up.   
Variables 
Baseline  Follow-up 
Mean (SD) or % n Mean (SD) or % n 
Age (years) 53.6 (7.3) 2096 56.7 (7.1) 1613 
Height (m) 1.63 (1.0) 2049 1.64 (9.2) 1502 
Weight (kg) 73.2 (14.1) 2082 73.2 (13.7) 1575 
Body mass index (kg/m2) 27.4 (4.5) 2041 27.2 (4.3) 1491 
Male  44.8% 940 44.9% 725 
Current smokers 36.2% 759 30.8% 496 
Work-related physical activity a 18.8% 393 20.8% 336 
Leisure-time physical activity a 54.2% 1137 66.0% 1064 
Type 2 diabetesb  10.9% 229 13.0% 210 
Low back painb 32.2% 675 36.8% 593 
Neck painb 28.4% 595 24.8% 400 
Spinal pain^b 18.2% 381 14.8% 239 
^ Spinal pain: concurrent lower back and neck pain; SD: standard deviation; n: number of 
participants; a Percentage engaged in physical activity within group; b Prevalence.    
84
Type 2 diabetes and chronic spinal pain (both LBP and NP) 1 
The analyses, including cross-sectional data from the total sample, demonstrated that type 2 2 
diabetes was associated with chronic spinal pain [unadjusted odds ratio (OR) 1.49; 95% CI 1.07 3 
to 2.09; adjusted OR 1.61; 95% CI 1.12 to 2.31] and severe chronic spinal pain (unadjusted OR 4 
2.94; 95% CI 1.44 to 5.99; adjusted OR 3.33; 95% CI 1.47 to 7.53) (Table 2). When the analyses 5 
were separated by sex, type 2 diabetes was associated with chronic spinal pain in females only 6 
(unadjusted OR 1.76; 95% CI 1.17 to 2.66; adjusted OR 1.64; 95% CI 1.06 to 2.53). However, 7 
for severe chronic spinal pain, type 2 diabetes was strongly associated among both females 8 
(unadjusted OR 2.71; 95% CI 1.03 to 7.11), and males (unadjusted OR 3.46; 95% CI 1.13 to 9 
10.59; adjusted OR 4.80; 95% CI 1.37 to 16.84). After adjusting for genetic and shared 10 
environmental factors using 201 and 26 twin pairs discordant for chronic spinal pain and severe 11 
chronic spinal pain respectively, the magnitude of association reduced and was no longer 12 
significant. 13 
14 
The longitudinal analysis for the total sample showed no association between type 2 diabetes and 15 
risk of developing severe chronic spinal pain after two to four years follow-up. Likewise, 16 
presence of chronic spinal pain did not increase the risk of future type 2 diabetes. 17 
[Table 2] 18 
19 
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Type 2 diabetes and chronic NP 1 
The cross-sectional analysis of the total sample demonstrated that type 2 diabetes was associated 2 
with chronic NP (unadjusted OR 1.35; 95% CI 1.02 to 1.79; adjusted OR 1.37; 95% CI 1.01 to 3 
1.85) (Table 3). When the analysis was separated by sex, type 2 diabetes was only associated 4 
with chronic NP in females (unadjusted OR 1.72; 95% CI 1.18 to 2.51; adjusted OR 1.58; 95% 5 
CI 1.07 to 2.34). The positive associations in the total and female only samples did not remain 6 
significant after adjustment for genetic and shared environmental factors using 276 and 139 twin 7 
pairs discordant for chronic NP, respectively. 8 
9 
We also found that type 2 diabetes was strongly associated with higher prevalence of severe 10 
chronic NP (unadjusted OR 2.11; 95% CI 1.17 to 3.79; adjusted OR 2.28; 95% CI 1.24 to 4.21). 11 
When the analyses were separated by sex, type 2 diabetes was associated with severe chronic NP 12 
in females only in the unadjusted analysis (OR 2.28; 95% CI 1.04 to 5.04) and was close to 13 
statistical significance in the adjusted analysis (OR 2.19; 95% CI 0.99 to 4.87). The positive 14 
associations for severe chronic NP in the total and female only samples did not remain after 15 
adjustment for genetic and shared environmental factors in 43 and 15 discordant twin pairs, 16 
respectively. In the total sample analysis using longitudinal data, type 2 diabetes did not increase 17 
the risk of developing chronic NP, or vice-versa, after two to four years. 18 
[Table 3] 19 
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Type 2 diabetes and chronic LBP 1 
The cross-sectional analysis of the total sample showed that type 2 diabetes was only associated 2 
with higher prevalence of severe chronic LBP in the adjusted total sample analysis (OR 1.63; 3 
95% CI 1.00 to 2.64). After adjusting for genetic and shared environmental factors using 73 twin 4 
pairs discordant for severe chronic LBP, the association was no longer significant. The 5 
longitudinal analyses showed that type 2 diabetes did not increase the risk of developing chronic 6 
LBP, or vice-versa, after two to four years. 7 
[Table 4] 8 
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Discussion 1 
Main findings 2 
Our findings suggest a positive association between type 2 diabetes and chronic back pain in the 3 
cross-sectional analyses. Those in our cohort with type 2 diabetes were more likely to report 4 
chronic low back, neck, and spinal pain. The associations tended to be stronger for severe cases 5 
of chronic pain (e.g. severe chronic spinal pain: adjusted OR 3.33) than any pain (chronic spinal 6 
pain: adjusted OR 1.61). Nevertheless, our findings do not provide strong and conclusive 7 
evidence of a causal relationship between type 2 diabetes and back pain. Firstly, none of the 8 
associations remained significant after further adjusting for the genetic and early environmental 9 
factors shared by twins. Moreover, no statistically significant association was found in the bi-10 
directional longitudinal analyses, although large magnitudes in risks were produced when 11 
diabetes was investigated as a risk factor for severe spinal pain. The presence of positive 12 
associations only in the cross-sectional analyses, in which confounders are partially controlled, 13 
suggest that type 2 diabetes and back pain could be linked by other mutually shared common risk 14 
factors (e.g. genetics). 15 
16 
Association of back pain and type 2 diabetes 17 
Back pain and other musculoskeletal pain disorders are common among patients with diabetes 18 
(7, 8, 11, 32-34). Despite this, there is a scarcity of well controlled studies that have attempted to 19 
disentangle this relationship. This may be due to back pain possibly being considered a trivial 20 
comorbidity compared with other major health problems associated with diabetes, such as heart 21 
disease or stroke (33). Nevertheless, compelling evidence suggests that people who suffer from 22 
type 2 diabetes and back pain usually present with greater signs of poor general health (e.g. 23 
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hypertension and dyslipidemia) and progress to worse outcomes such as increased pain severity 1 
(6, 33, 35, 36). In agreement with previous studies, we found that type 2 diabetes was more 2 
strongly associated with severe cases of chronic spinal pain (adjusted OR 3.33, 95% CI 1.47 to 3 
7.53), NP (adjusted OR 2.28, 95% CI 1.24 to 4.21), and LBP (adjusted OR 1.63, 95% CI 1.00 to 4 
2.64). 5 
6 
Our cross-sectional results also indicated the association between diabetes and chronic neck and 7 
spinal pain tended to be more consistent, and often stronger, among females than in males. The 8 
underlying mechanisms for this difference is still unknown, but several reasons could be 9 
speculated. For example, sex hormones that are predominant in females (e.g. estrogen) can affect 10 
the immune system and increase the inflammatory response, which may result in a greater 11 
predisposition to develop diabetes and spine degeneration (37-42). Higher prevalence of back 12 
pain and more rapid changes in spine degeneration have been reported in females after 13 
menopause (38, 40-44). In our sample, most females were in their mid-life period (mean age: 54 14 
years), which coincides with the timing of menopausal age (45). As the majority of women with 15 
type 2 diabetes are older and frequently diagnosed during or after menopause (38), the 16 
understanding of underlying mechanisms of back pain and degeneration in this population may 17 
deserve further exploration. 18 
19 
Causal relationship between type 2 diabetes and back pain 20 
In light of the findings from the cross-sectional co-twin and the longitudinal analyses, the 21 
relationship between type 2 diabetes and back pain might not be as simple or direct as previously 22 
believed. After further adjustment for a large number of potential disease confounders, such as 23 
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genetics and early environmental factors shared by twins, the significant associations between 1 
type 2 diabetes and back pain did not persist suggesting that a causal relationship between the 2 
two diseases is not likely. Our findings are consistent with results from two other twin studies 3 
that investigated lumbar spine degeneration in twin pairs discordant for diabetes status (24, 46). 4 
One of these studies (24) investigated lumbar spine degeneration and bone density, using 5 
magnetic resonance imaging, among nine MZ twin pairs discordant for insulin-dependent 6 
diabetes. No difference was observed in lumbar disc degeneration or bone density scores 7 
between twins with or without a diagnosis of diabetes (24). Likewise, a recent co-twin study 8 
including 33 MZ and DZ pairs discordant for type 2 diabetes reported that twins with type 2 9 
diabetes did not present with higher lumbar degeneration scores than those without (46). The 10 
findings from our study and these other co-twin studies (24, 46) indicate that a causal link 11 
between these health conditions are unlikely. Similarly, our longitudinal analyses showed that 12 
type 2  diabetes possibly does not increase the risk of back pain, or vice-versa,  suggesting no 13 
temporal effect, one of the important indicators of a causal relationship between variables (47). 14 
However, we acknowledge that the lack of significant associations in our co-twin and 15 
longitudinal analyses may be due to the small sample size, which reduces the power required to 16 
identify a relationship, if in fact, it exists. Some large magnitude in risks were identified (e.g. 17 
diabetes as a risk factor for severe spinal pain, particularly in women), and might reveal as 18 
statistically significant if larger samples of twins were available. 19 
20 
Implications of study findings for clinical practice and research 21 
Although our results question a possible causal relationship between type 2 diabetes and back 22 
pain, this study suggests that LBP and NP are associated with type 2 diabetes. Our findings 23 
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provide guidance for health professionals that people with both diabetes and back pain are more 1 
likely to present with more severe levels of pain compared to those without diabetes. Screening 2 
for back pain in patients with diabetes could be incorporated in clinical settings as an approach to 3 
avoid subsequent pain-related disability and minimize the progression of back pain and diabetes. 4 
At present, to our knowledge, only one study has investigated the efficacy of an intervention for 5 
this population, and found that osteopathic manual treatment resulted in a clinically relevant 6 
reduction of LBP severity over 12 weeks (medium effect size; Cohen d=0.7) compared to sham 7 
treatment. Interestingly, better metabolic profile was also observed in the intervention group after 8 
treatment as serum concentration of TNF-α significantly reduced. TNF-α is considered a 9 
contributing factor for metabolic disturbances such as insulin resistance and dyslipidemia in type 10 
2 diabetes (48). Consequently, studies are needed to investigate interventions that can be 11 
delivered to patients suffering from both back pain and diabetes with the aim of minimizing 12 
diseases’ progression and their related complications. 13 
14 
Strengths and Limitations 15 
The strengths of our study include the use of a co-twin design, allowing for within-twin pair 16 
comparisons naturally adjusted for genetics and other shared childhood factors such as diet and 17 
parental characteristics (e.g. socioeconomic status and lifestyle), that could affect both diabetes 18 
and back pain.  In addition, we only included participants with a confirmed diagnosis of diabetes 19 
(via the Spanish Health Registry), which adds validity to the ascertainment of the presence of 20 
diabetes. An investigation of causality using longitudinal data accompanied the cross-sectional 21 
analyses, to assess whether there was a bi-directional relationship between type 2 diabetes and 22 
back pain. 23 
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There are also potential limitations that should be taken into account when interpreting our 1 
results. Firstly, as expected due to the moderate back pain heritability (25, 26), there were few 2 
twin pairs discordant for back pain identified in our sample. As a result, it is possible that some 3 
co-twin analyses were underpowered. Nevertheless, the matching generated by the co-twin 4 
design may have the potential to overcome this limitation (49, 50). Furthermore, our findings 5 
were consistent with two other previously published co-twin studies (24, 46). Inadequate power 6 
could have also affected the statistical significance and confidence intervals observed in our 7 
longitudinal analyses. Secondly, two to four years follow up may be short considering the 8 
chronic and progressive deleterious effect that type 2 diabetes and back pain can have on health. 9 
Therefore, the temporal relationship between these conditions may need to be explored over 10 
longer period of time. Lastly, the generalizability of our results to global populations needs to be 11 
undertaken with caution. Our sample comprised older Spanish people from a Mediterranean 12 
region (Murcia) with a high prevalence of obesity and type 2 diabetes (51). Therefore, before 13 
drawing definitive conclusions, we emphasize the need for further prospective twin studies using 14 
a more heterogeneous and larger cohort. 15 
16 
In summary, chronic back pain (NP, LBP and both) was associated with the prevalence of type 2 17 
diabetes. Stronger associations were observed for more severe cases of pain. Genes or 18 
environmental factors that influence both conditions should not be excluded as factors 19 
confounding these associations. Given the increasing global prevalence of back pain and 20 
diabetes, further studies are warranted to understand the mechanisms behind these associations, 21 
as well as the strategies to optimize management and healthcare utilization in this population. 22 
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Twins from the Murcia Twin Registry with data available for type 2 diabetes
and chronic back pain [low back pain (LBP), neck pain (NP) or both]. 
Number of participants: 2096 
Baseline (Data collected between 2009 and 2011) 
Cross-sectional analysis. Type 2 diabetes and chronic back pain (chronic NP, or LBP, or both 
independently). All participants with data available for back pain and type 2 diabetes were included, 
except for the case-control analysis where only complete and discordant pairs for chronic NP, or 
LBP or both were included. Analysis stages:  
1. Total sample analysis unadjusted
2. Total sample analysis adjusted (Confounding factors investigated: age, sex, BMI, smoking,
engagement in physical activity) 
3. Within-pair twin case-control analysis (confounding factors investigated age, sex, BMI, smoking,
engagement in physical activity, genetics and early environmental factors shared by twins) 
Follow-up (Data collected in 2013) 
Cross-sectional analysis. Type 2 diabetes and chronic severe back pain (chronic NP, or LBP, or 
both independently). All participants with data available for severe back pain and type 2 diabetes 
were included. Analysis stages:  
1. Total sample unadjusted
2. Total sample adjusted (confounding factors investigated age, sex, BMI, smoking, engagement in
physical activity) 
3. Within-pair twin case-control analysis (confounding factors investigated age, sex, BMI,
smoking, engagement in physical activity, genetics and early environmental factors shared by 
twins) 
Longitudinal analysis. Type 2 diabetes as a predictor for chronic back pain (chronic NP, or LBP, 
or both independently). All participants with data available for back pain and type 2 diabetes who 
were free of chronic NP (or LBP, or both) at baseline. Analysis stages: 
1. Total sample unadjusted
2. Total sample adjusted (confounding factors investigated age, sex, BMI, smoking, engagement in
physical activity) 
Longitudinal analysis. Chronic back pain (chronic NP, or LBP or both independently) as a 
predictor for type 2 diabetes. All participants with data available for back pain and type 2 diabetes 
who were free of diabetes type II at baseline. Analysis stages: 
1. Total sample unadjusted
2. Total sample adjusted (confounding factors investigated age, sex, BMI, smoking, engagement in
physical activity) 
Figure
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CONCLUSIONS AND IMPLICATIONS 
6.1 Purpose of the thesis  
 The broad aim of this thesis was to contribute to a better understanding of whether 
obesity-related measures - general obesity, abdominal obesity, and type 2 diabetes - are risk 
factors for the development of low back pain (LBP), particularly chronic LBP.  To date, much 
research examining potentially modifiable risk factors for LBP has been conducted. Identifying 
potentially modifiable risk factors, such as obesity, could lead to the development and 
implementation of evidence-based preventive strategies for LBP and associated disability. 
However, minimal progress has been made in identifying potentially modifiable risk factors and 
developing preventive approaches. As such, the evidence on the relationship between obesity-
related risk factors and LBP remains conflicting. Methodological flaws, such as the lack of 
adjustment for important confounders and the use of suboptimal obesity measures, likely explain 
the controversial findings.  
To investigate the link between obesity-related risk factors and LBP, the studies that 
compose this thesis used a twin case-control design. The highly matched twin case-control 
design accounts for a range of potential confounders, including genetics and early environmental 
factors. Theoretically, this methodology can shed more light on the nature of the association 
between obesity and LBP by determining whether there is a direct (causal) relationship between 
these conditions. To overcome the limitation of previous studies that used suboptimal measures 
of obesity, the studies in this thesis used a comprehensive assessment of obesity that considered 
the magnitude of fatness as well as the body fat distribution. This thesis also sought to 
investigate whether obesity-related risk factors fulfil several criteria that are considered decisive 
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for confirming a direct (causal) link between exposure and an outcome, including the strength of 
association, consistency, and temporality [1, 2]. 
6.2 Overview of main findings  
 The initial objective of this thesis was to investigate whether obesity is a risk factor for 
LBP and lumbar disc degeneration.  A comprehensive literature search and appraisal was 
conducted to summarise the findings of twin studies in a systematic review with a meta-analysis 
approach (Chapter Two). This study revealed a positive association between obesity and both 
LBP and lumbar disc degeneration in the least adjusted models (unpaired analyses in which 
familial factors were not taken into account). Most (four out of five) of the cross-sectional twin 
studies included in this review reported positive associations between obesity and LBP, 
suggesting consistency of findings and therefore enhancing the possibility of obesity being a risk 
factor for LBP. Nonetheless, the pooling of these five studies showed that obesity was weakly 
(odds ratio <2.0) associated with  LBP (odds ratio [OR] 1.8; 95% confidence interval [CI] 1.6 to 
2.0)[2]. Additionally, pooling of the studies that controlled for familial factors, including 469 
identical (monozygotic - MZ) twins discordant for body weight status, revealed a reduction in 
the strength of association which was then no longer significant (OR 1.4; 95% CI 0.8 to 2.3). The 
findings of this systematic review with meta-analysis provided a different perspective to the LBP 
field, suggesting the possibility of genetics and familial factors confounding the relationship 
between obesity and LBP. Furthermore, Chapter Two highlighted limitations in previous 
studies such as imprecise measures used to define obesity (e.g. body mass index - BMI) and a 
lack of longitudinal twin studies.  
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 Chapters Three and Four have attempted to address the limitations revealed in Chapter 
Two by evaluating the effect of four measures of obesity that consider the effects of magnitude 
(BMI; percentage of fat mass) and distribution of body fat mass (waist circumference - WC; 
waist-hip ratio - WHR) on chronic LBP. Cross-sectional and longitudinal data from Spanish 
twins were used to conduct the studies reported in Chapters Three and Four, respectively. 
Results from Chapter Three demonstrated that greater magnitude of fat (measured by BMI and 
percent of fat mass), as well as higher distribution of fat mass around the hips (measured by 
WHR), were associated with higher prevalence of chronic LBP in females. However, the 
associations were weak and did not remain significant after further control for the effects of 
familial factors shared by MZ twins. Chapter Four showed that obesity-related factors did not 
increase the risk of chronic LBP, activity-limiting LBP, or care-seeking for LBP after two to four 
years follow-up. Furthermore, no evidence of a dose-response relationship was found in any of 
the analyses. The lack of temporal effect and dose-response relationship are in agreement with 
the findings reported in Chapters Two and Three, suggesting that a direct link between obesity 
measures and chronic LBP outcomes is unlikely.  
 A Supplementary Analysis presented in Chapter Four further questioned obesity-
related measures as strong risk factors for LBP, when the influences of genetic and shared 
environmental factors are considered. The results revealed that the within-pair concordance rates 
within-pair for obesity-related measures did not differ according to the presence or absence of 
LBP in 31 Australian MZ twin pairs. Essentially, twins with LBP were not generally heavier 
than their co-twins without LBP. Furthermore, due to the high concordance rates in obesity 
measures and LBP phenotypes within-pairs, the findings reinforced the possibility of shared 
genetics and familial factors confounding the link between obesity-related measures and LBP.  
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 The final study of this thesis reported in Chapter Five investigated the relationship 
between chronic back pain (including LBP, neck pain, or both) and another obesity-related 
health risk factor: type 2 diabetes. Results of the cross-sectional analysis indicated that chronic 
back pain was associated with the prevalence of type 2 diabetes. Importantly, for the first time, 
evidence of stronger associations between type 2 diabetes and severe concurrent chronic LBP 
and neck pain were reported (OR 3.3; 95% CI 1.5 to 7.5). However, similar to the findings of 
Chapters Two, Three, and Four, none of the associations remained significant after further 
adjustment for genetics and early environmental factors shared by twins. The longitudinal 
analyses also showed that the presence of type 2 diabetes did not increase the risk of future back 
pain, or vice-versa, after two to four years of follow up. Ultimately, the findings of Chapters 
Two to Five show that obesity-related measure are unlikely to be directly linked to chronic LBP. 
Genetics and early environmental factors are plausible confounding factor for the link between 
obesity-related measures and LBP. 
 
6.3 Limitations of the thesis  
 When interpreting the findings of this thesis, potential limitations should be taken into 
consideration. First, an assumption presented earlier in this thesis in regards to MZ and dizygotic 
(DZ) twin pairs sharing a similar environment may not be entirely correct. MZ twins tend to 
share demographic and lifestyle factors (e.g. education, smoking habits, and exercise habits) to a 
greater degree than DZ twins [3]. Although this issue does not affect the estimates presented in 
the thesis, the greater concordance rates of environmental exposures in MZ twins should be 
considered when interpreting the results. For example, the differences in MZ and DZ case-
control estimates should not be interpreted as purely genetically driven. Second, in the MZ case-
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control analyses presented in Chapters Three, Four, and Five, the number of twin pairs 
discordant for chronic LBP was often less than 50 pairs, which may reduce the precision of the 
estimates. While these numbers are relatively small, the use of a highly matched twin case-
control design may reduce the demand on large sample sizes. Furthermore, results from the case-
control analyses (Chapter Three, Four, and Five) are consistent with the meta-analysis 
(Chapter Two) that included a greater number of MZ twin pairs (>400 MZ pairs) and other twin 
studies in the field [4, 5]. This suggests that the findings of Chapters Three, Four and Five are 
plausible. 
Third, another potential limitation of the thesis is related to the effect of the duration of 
the exposures (obesity or type 2 diabetes) on LBP. It is possible that the proposed biological 
mechanisms underlying the link between obesity or type 2 diabetes and spinal degeneration (e.g. 
overload or low-grade systemic inflammation) are slow and progressive. The follow-up duration 
in the longitudinal analyses of this thesis (Chapters Four and Five) were no longer than four 
years. As such, the temporality effect (time frame of a potential cause and effect) may need to be 
explored with longer follow-ups. In addition, objective obesity-related data (percentage of body 
fat, and waist and hip circumference) presented in Chapters Three and Four were available 
only for females. Hence, this can affect the generalisability of the study findings to males.  
 Finally, in Chapter Four, the investigation of a dose-response relationship between 
obesity and LBP revealed that higher levels of obesity did not result in greater risk of chronic 
LBP. However, in this study, severe obesity was not distinguished from overweight or obesity. 
According to a recent cross-sectional MZ twin case-control study, not overweight or obese twins, 
but those twins with severe obesity have a higher chance of reporting chronic LBP (OR 3.7; 95% 
CI 1.2 to 11.4) compared to co-twins who are of normal weight [4]. This indicates the need for 
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further studies using twin pairs who are highly discordant for obesity levels. Nevertheless, 
despite the uncertainty around the role of obesity being regarded as a risk factor for chronic LBP, 
from a public health perspective, preventing severe levels of obesity should be recommended as 
an attempt to reduce the risk of a number of obesity-related comorbidities (e.g. cardiovascular 
disease, type-2 diabetes, and some cancers) [6-9]. 
6.4 Implications of the thesis and directions for future research 
 The main results of this thesis reveal that obesity-related factors are unlikely to be strong, 
direct, and consistent risk factors for the development of chronic LBP. This new evidence likely 
explains the lack of effectiveness of interventions targeting weight reduction to reduce LBP 
incidence in adults [10]. The relevance of familial factors such as genetics and environmental 
factors, and perhaps the interactions between these factors, as plausible risk factors for the 
development of both obesity and chronic LBP, should not be disregarded. The genetic 
architecture and gene-environment interactions that influence obesity and chronic LBP are likely 
complex [5]. However, genetic testing for these highly prevalent and multi-dimensional chronic 
health conditions is neither clinically applicable nor cost-effective [11, 12]. Therefore, 
considering the implications and applicability of the findings of this thesis to guide best practice 
and future research, several key topics will now be considered. 
6.4.1 Prevention: Early family-based interventions  
A recognised characteristic of LBP, particularly for chronic LBP, is that it tends to cluster 
in families [13, 14]. The studies that compose this thesis and the vast majority of twin and family 
research in the field have consistently indicated genetics and familial factors, and perhaps their 
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interaction, as contributing factors for LBP [4, 13-22]. In light of the strong evidence for familial 
factors influencing chronic LBP, preventive interventions that are narrowly focused on one 
health/environmental aspect (e.g. weight loss) later in life, without changing fundamental 
characteristics of the early family environment, are likely to be insufficient to reduce the risk of 
chronic LBP. A novel strategy warranting evaluation in future research is early family-based 
preventive interventions for chronic LBP. Individuals at risk would be identified through their 
family history of chronic LBP [13, 14]. Targeting the family unit as a means to improve lifestyle 
behaviours (e.g. physical activity, diet, and cognitive coping skills) has been proven successful to 
reduce the risk and impact of other chronic health conditions such as obesity, diabetes (type 1 
and 2), and chronic pain [23-28]. These results from other fields highlight the value of family-
based interventions that could potentially be applied in chronic LBP. Interventions of this nature 
provide an innovative and promising approach to reduce the risk of chronic LBP, as well as other 
chronic health conditions that often coexist with chronic LBP such as obesity and type 2 
diabetes. 
6.4.2 Management of chronic low back pain  
Taken in isolation, chronic LBP or obesity (and/or type 2 diabetes) pose enormous 
challenges to patients, clinicians, and the healthcare system. Importantly, negative impacts on 
health seem to be exacerbated further when these conditions present concomitantly. 
Multimorbidity has a greater impact on physical deterioration, quality of life and mortality 
compared to having one health condition in isolation [29, 30]. The coexistence of chronic health 
conditions increases the complexity of healthcare services needed by patients [31]. The presence 
of comorbidities has also been associated with significant longer duration of LBP-related work 
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disability and higher healthcare costs [32-34]. Furthermore, disability retirement due to LBP is 
twice more common in overweight or obese individuals than those with normal weight (OR 2.0; 
95% CI 1.6 to 2.6) [35]. Therefore, although the main findings of this thesis suggest no direct 
causal link between obesity and LBP, the importance of obesity and type 2 diabetes as 
comorbidities for chronic LBP is not diminished.  
The studies reported in Chapters Two, Three, and Five revealed a consistent positive 
association between obesity-related factors and chronic LBP in cross-sectional analyses 
(unpaired analysis). Importantly, Chapter Five showed that individuals with type 2 diabetes 
were three times more likely to present with concurrent severe pain (visual analogue scale for 
pain ≥ 9 out of 11 points) in both the lower back and cervical regions. Hence, the understanding 
of mechanisms underlying these association (e.g. metabolic mediators), as well as the design of 
healthcare interventions considering obesity-related comorbidities, should be considered in 
future research to enhance management of chronic LBP. 
6.4.2.1 Metabolic mediators 
The mechanisms underlying the associations between obesity, type 2 diabetes, and 
chronic LBP are likely to be diverse and multifactorial [5, 12]. Familial factors may partially 
explain these associations, yet it is also likely that other metabolic mediators could play a role in 
these links. Growing evidence suggests metabolically driven inflammation as a possible 
pathophysiological link between obesity, type 2 diabetes, and chronic pain [36, 37]. Preliminary 
evidence suggests that LBP and obesity-related factors are often associated with a low-grade 
systemic inflammatory phenotype, indicated by higher levels of pro-inflammatory markers (IL-
1β and TNF-α). This could affect both pain perception and disease progression in conditions 
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such as LBP and diabetes [38-40]. Importantly, the pro-inflammatory mediator C-reactive 
protein (CRP) is elevated in obese individuals [41-43], and obese adults with elevated CRP are 
more likely to report LBP than those with normal CRP levels [44, 45]. Moreover, greater signs 
of spinal degeneration are present in individuals with chronic LBP who have high serum CRP 
levels [46]. Given this evidence, it is likely that low-grade inflammation due to obesity and type 
2 diabetes could influence chronic LBP outcomes. A better understanding of endocrine and 
metabolic mediators providing a mechanistic link between LBP and obesity-related factors 
would yield a stronger physiological basis to inform the design of novel therapies such as anti-
inflammatory or analgesic drugs. Consequently, future research should determine the 
significance of metabolic pathways to control the progression of chronic LBP in individuals with 
concurrent obesity and/or type 2 diabetes, in particular individuals with severe pain.   
6.4.2.2 Novel approaches to managing individuals with concurrent chronic LBP and obesity 
(and/or type 2 diabetes) 
Traditional models of care are failing to significantly reduce care-seeking and costs 
associated with the management of chronic LBP [47-51]. This unsatisfactory success may be due 
to the limitations of conventional clinical management of chronic LBP that often relies on 
monotherapies which involve face-to-face interactions between the healthcare provider and the 
patient [52, 53]. Most monotherapies for chronic LBP such as physiotherapy, analgesics, and 
non-steroidal anti-inflammatory drugs have limited efficacy in LBP [53, 54]. As chronic LBP 
often coexists with other comorbidities such as obesity and type 2 diabetes, increasing 
complexity of care, focusing on the management of individual chronic conditions may not be 
sufficient to achieve treatment success [31, 55]. Efforts towards developing management 
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approaches that are effective across different chronic illnesses (e.g. chronic LBP and obesity) 
should be emphasised to ensure integration of healthcare, which could also impact heath 
expenditure [34]. Put simply, this approach would minimise costs due to the elimination of 
duplication of healthcare services, thereby optimising limited resources [34, 55].  
Considering high costs associated with care and limited access to treatment for those with 
chronic LBP and obesity, innovative methods for healthcare delivery such as telehealth-based 
interventions should be encouraged [31, 56, 57]. Currently, telehealth-based interventions are 
successfully used to manage obesity and type 2 diabetes [58-61]. However,  the benefits of 
telehealth-based interventions are limited for individuals with chronic LBP. This evidence is 
from an unpublished systematic review conducted by our group (Appendix B). This systematic 
review demonstrates that telehealth-based interventions implemented as a unique management 
strategy for chronic LBP are not effective in reducing pain and disability (Appendix B). The 
small effect size identified may be explained by the inherent complexity of chronic LBP 
management which was not considered in the telehealth-based models. For example, none of the 
interventions included in the review addressed other common LBP-related comorbidities such as 
obesity or type 2 diabetes.  
To promote optimal patient care focussing on maximising health goals, integration of 
interventions using telehealth should be explored for individuals with chronic LBP and obesity-
related comorbidities. Notably, the protocol of the first randomised clinical trial designed to 
evaluate the effectiveness of a telephone-based lifestyle behavioural intervention for patients 
with concurrent LBP and obesity has recently been published [31]. Lifestyle behavioural 
interventions delivered remotely by phone will be compared to usual care among patients on a 
waiting list for spinal surgery [31]. Participants will receive ten individually tailored coaching 
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calls over a six-month period including brief advice and education about the benefits of weight 
loss and physical activity. Likewise, trials exploring the potential of telehealth-based 
interventions for individuals with concurrent chronic LBP and type 2 diabetes are needed. 
Individuals with type 2 diabetes commonly present with poor glycaemic control that may lead to 
worsening of frequency and severity of LBP and other related comorbidities [62-64]. Telehealth-
based interventions are effective in improving glucose control [59, 65-68]. Hence, another 
important future direction is to explore whether integrated healthcare through telehealth can 
enhance patient care at a lower costs while improving health outcomes related to chronic LBP 
and obesity-related comorbidities. 
6.5 Final conclusions 
Taken together, the results of the twin studies presented in this thesis provide novel 
information that generate a better understanding of the complex relationships between obesity 
and LBP. Although obesity and chronic LBP often coexist, a direct link between them is 
questionable as the associations are mostly weak with no evidence of temporality. Additionally, 
findings from the twin analyses indicate that these health conditions coexist possibly due to 
common genetics and early shared environmental influences on their pathogenesis. In light of 
this new evidence, innovative studies have been proposed. An important future consideration for 
the prevention of LBP is to investigate whether early family-based interventions targeting 
modifiable lifestyle behaviours can reduce the incidence of chronic LBP and related disability in 
youth. This would present an advanced step in a field which urgently requires novel, evidence-
based, cost-effective approaches to minimise the individual and societal burden of LBP.   
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Is there a link between obesity and back pain?
AUGUST 4, 2015 BY BIM
A big belly isn’t necessarily a pain in the back
Over 80% of Australians experience back pain at some point in their lives, which is one of 
the most common reasons people miss work and seek health care. Despite the efforts of the 
scientific community to identify risks factors for back pain, the cause of this condition is still 
poorly understood. Knowing what causes low back pain might help us prevent its occurrence.
The Back Pain Group from the University of Sydney’s Faculty of Health Sciences is currently 
investigating different factors that increase the risk of back pain such as genetics and obesity 
related measures. Extra loading on the spine and inflammation are proposed mechanisms 
that could explain why obese individuals could be at higher risk of developing back pain. 
However, the evidence is still unclear.
According to our new research investigating twins it could be our genes – not those extra 
kilos – that are causing back pain.  We have recently published two novel twin studies, in 
The Spine Journal and in The European Spine Journal that debunk the direct link between 
obesity and low back pain. The articles show that the relationship between obesity and low 
back pain is more likely the result of shared genetic factors.
The first study, including 1128 Spanish female twins, is the result of collaboration between 
researchers from the University of Sydney and Spain’s Murcia Twin Registry [1]. The second 
is a paper summarizing the findings from twin studies conducted in four different countries with 
participants ranging from 12 to 84 years-of-age [2].
Studying obesity and back pain in twins gives us a unique opportunity to control for various 
shared genetic factors that can influence people’s health. The strongest results are seen 
when investigating these health conditions in identical twins because these twins share 
almost one hundred percent of their genes.
Twin studies give us a less biased estimate of risk for conditions like back pain by controlling 
for possible confounding from genetic factors and early shared environment. On the surface, it 
appears that overweight and obese people are twice as likely to have lower back pain. 
However this association diminishes when factoring in genetic and familial confounders among 
twins.
122
Is there a link between obesity and back pain?
The studies suggest that genes common to both low back pain and obesity might be 
responsible for the relationship between these conditions. From here, where do we go? 
Currently, to confirm these results, we are conducting a new study that follows the Spanish 
twins and checks if those who are obese have a higher risk of developing back pain over 
time. The project is underway and the results will soon be available.
For a long time we thought targeting obesity and prescribing weight loss could help alleviate 
the prevalence of back pain in the community but these studies call for a rethink. Hopefully 
these results will contribute to the field and inform policy makers on whether obesity 
increases, or not, the risk of back pain. This knowledge has the potential to help the design of 
future preventative strategies for back pain. We think the proverb from 17th century is still 
valid for today: “An ounce of prevention is worth a pound of cure – Benjamin Franklin”.
Amabile completed her physiotherapy and honours degrees at Santa 
Catarina State University in Brazil. At the same university, she 
undertook a Master degree on the effect of aquatic exercise in people 
with active rheumatoid arthritis. At the University of Sydney, Amabile 
is conducting a PhD focusing on risk factors for low back pain and 
was lead author on these twin studies. 
Her research career has focused on chronic pain and she is currently a member of the 
Arthritis and Musculoskeletal Research Group at the Faculty of Health Sciences – University of 
Sydney.
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APPENDIX B 
Effectiveness of telehealth-based interventions in the management of non-
specific low back pain: a systematic review with meta-analysis. 
This systematic review has been under review in The Spine Journal since 18 August 2016, and it is in 
the format required by this journal.  
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Abstract: Background: Telehealth has emerged as a potential alternative 
to deliver interventions for low back pain (LBP), however its 
effectiveness has not been investigated.  
Purpose: The aim of this review was to evaluate whether interventions 
delivered by telehealth improve pain, disability, function, and quality 
of life in non-specific LBP.  
Study Design: Systematic review with meta-analysis 
Methods: Seven databases were searched from the earliest records to 
August 2015. Eligible studies were randomized controlled trials that 
investigated the effectiveness of telehealth-based interventions, solo or 
in combination with other interventions, for non-specific LBP compared to 
a control group. Trials deemed clinically homogeneous were grouped in 
meta-analyses. 
Results: Eleven studies were included (N = 2280). In chronic LBP, 
telehealth interventions had no significant effect on pain at short [four 
trials; 1,089 participants; weighted mean difference (WMD) -2.61 points; 
95% CI: -5.23 to 0.01] or medium-term follow-up (two trials; 441 
participants; WMD: -0.94 points; 95% CI: -6.71 to 4.84) compared to a 
control group. Similarly, there was no significant effect for disability. 
Results from three individual trials showed that telehealth was superior 
to a control intervention for improving quality of life. Interventions 
combining telehealth and usual care were more beneficial than usual care 
alone in people with recent onset of LBP symptoms. 
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Conclusion: There is moderate-quality evidence that current telehealth 
interventions, alone, are not more effective than minimal interventions 
for reducing pain and disability in chronic LBP. To date, modern 
telehealth media (e.g. apps) and telehealth as an adjunct to usual care 
remain understudied.  
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Introduction 1 
Low back pain (LBP) is a major public health problem with lifetime prevalence estimated at 39% worldwide, 2 
affecting people across the whole age spectrum[1,2]. LBP is the leading cause of years lived with disability[3] with 3 
costs associated with treatment being extremely high, exceeding €12 billion a year in the European Union[4,5]. As 4 
the population ages, a substantial increase in the disease burden of LBP is expected[6].  5 
6 
It is recognized that traditional healthcare models have failed to significantly reduce care-seeking and costs 7 
associated with treatment[7-11]. Conventionally, clinical management of LBP relies on face-to-face interactions 8 
between the health care provider and the patient[12]. However, this approach is not affordable or accessible for a 9 
large number of individuals, particularly those living in remote locations. Given the increase in use of technologies 10 
to enhance health services[13], telehealth has emerged as a potential alternative to deliver interventions for LBP. 11 
Telehealth refers to health services delivered remotely via electronic communication media (e.g. websites, 12 
telephone) aimed at improving individuals’ health status by providing education and services, reducing healthcare 13 
cost, and overcoming geographic barriers[14-16]. Potentially, interventions listed in the most recent clinical practice 14 
guidelines for LBP (i.e. patient education, behavior therapy, and exercise programs)[17] could be delivered through 15 
telehealth. 16 
17 
The use of telehealth is growing in popularity and has shown to be effective in the management of a variety of other 18 
health conditions (e.g. obesity and asthma)[13,18-20]. Despite the growing interest in telehealth for people with 19 
LBP[19,21,20], little is known about the clinical effectiveness of this approach. Therefore, we conducted a 20 
systematic review and a meta-analysis to determine whether telehealth-based interventions are effective for reducing 21 
pain and disability, and for improving function and quality of life for people with LBP.  22 
23 
Methods 24 
A protocol for this review was registered a priori in PROSPERO (CRD42014010007). We also used the PRISMA 25 
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement) recommendations 26 
to guide the review[22].  27 
28 
*
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Search. MEDLINE, Embase, Web of Science, Scopus, CINAHL, PEDro, and Cochrane databases were searched 1 
using a combination of key words related to LBP, telehealth, and randomized controlled trials (RCTs) from earliest 2 
records to August 2015. Additionally, citation tracking was conducted of the reference lists of the included studies 3 
and relevant publications in the field. The search strategy used for each database can be found in the supplementary 4 
Appendix 1.  5 
6 
Selection of studies. The assessment process involved screening of titles, followed by abstracts, and finally full text 7 
by two investigators (LA, AM) independently. In cases of disagreement, consensus was reached with a third 8 
investigator (AD).  9 
10 
Eligibility criteria. Eligible studies were RCTs that investigated the effectiveness of any telehealth-based 11 
intervention, in isolation or in combination with other interventions, for non-specific LBP, compared to a control 12 
group. Non-specific LBP is defined as pain arising from the lumbar spine structures with no relevant neural 13 
compromise or serious spinal pathology such as fracture or cancer. Relevant outcomes were: pain, disability, 14 
function, and quality of life. No restriction on participants’ age and sex was applied. Telehealth strategies were 15 
defined as any type of health-related service (e.g. health education, exercise prescription, or goal-setting) delivered 16 
via telecommunication technologies such as telephone [call, short message service (SMS), applications (apps)] and 17 
internet (websites, e-mail). The control group could include no intervention, a waiting list, minimal intervention (i.e. 18 
non-health-related or LBP information), or usual care. Studies that included participants with a history of spinal 19 
surgery or serious spinal pathologies (i.e. cancer, fracture and systemic diseases) were excluded.  20 
21 
Data extraction. Two reviewers (LA, AM) independently extracted the data, including demographic information, 22 
intervention and control group characteristics, and outcomes. A third reviewer (MH) extracted data for non-English 23 
studies. Outcome data included mean scores, mean difference between groups, odds ratios, standard deviations (SD), 24 
and standard errors (SE). Outcomes were extracted for short-term (immediate effect post-treatment to ≤ 3 months 25 
follow-up), medium-term (> 3 months to 1 year follow-up), and long-term (>1 year follow-up) evaluations. When 26 
more than one assessment was performed in an interval (e.g. at 4 and 12 weeks), data from the longest period to 27 
follow-up were extracted. Results from intention-to-treat analyses were preferentially extracted. 28 
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1 
Data synthesis and analysis. For the meta-analyses, the outcomes were converted to a 0-100 scale and described as 2 
weighted mean differences (WMD) with 95% confidence interval (CI). The average pain score was used when trials 3 
evaluated more than one pain outcome (e.g. worst pain and average pain). When SD was not reported we calculated 4 
it from available SE (SE = SD/√n). Trials deemed clinically homogeneous were grouped according to: (i) outcome; 5 
(ii) follow-up length (i.e. short and medium-term); (iii) telehealth strategy (i.e. delivered in isolation or added to 6 
other intervention; and (iv) LBP chronicity (i.e. acute or chronic). Between-trial heterogeneity was evaluated by 7 
visual inspection of the forest plots and the I
2
 Statistic (I
2
<50%: low to moderate;  50%< I
2
<75%: substantial; 8 
I
2
>75% considerable heterogeneity)[23]. Pooled effects were calculated using fixed-models when low to moderate 9 
heterogeneity was found (i.e. I
2
 ≤ 50), otherwise random-models were used. Analyses were conducted with 10 
comprehensive Meta-Analysis software (Biostat, Englewood, NJ, version 2). 11 
12 
Assessment of trial methodological quality. Two independent reviewers (LA, AM) assessed the methodological 13 
quality of individual studies using the PEDro scale (0 - 10). This scale is a valid tool to assess the methodological 14 
quality of clinical trials, with acceptable reliability 
[24-26]
. Scoring disagreements were resolved by consensus,15 
however, if consensus could not be reached, the issue was resolved by a third reviewer (AD). When available, 16 
quality scores were extracted from the PEDro database (www.pedro.org.au). Studies with a PEDro score of 7 or 17 
greater were considered ‘high quality’, those with a score of 6 or less were considered low quality [27].18 
19 
Quality of evidence. Two independent reviewers (AD, MS) used an adapted version of the GRADE (Grading of 20 
Recommendations Assessment, Development and Evaluation) classification, to evaluate the quality of evidence and 21 
the strength of the recommendation in  high, moderate, low, and very low [28,29]. For each pooled estimate, the 22 
quality of evidence was initially considered as high and downgraded by one level based on five criteria: poor study 23 
design (>25% of participants from studies with low quality methods - PEDro score <7 points), inconsistency of 24 
results (I2>50%), publication bias (funnel plot), imprecision (sample size <400 for each outcome), and indirectness 25 
(i.e. comparison of different populations and interventions).  26 
27 
28 
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Results 1 
Description of included studies.  2 
Screening of titles and abstracts yielded 93 potentially eligible articles with 11 articles included after reviewing full-3 
text (Figure 1)[18,30-32,13,33-38]. Eight original RCTs were included (n = 2280 participants), as more than one 4 
publication reported data from the same trial[32,36,38,33,30]. Ten articles were published in English 5 
[18,32,36,34,37,38,33,30,35,13], and one was published in German [31]. The earliest publication was in 2002[18], 6 
while eight were published in 2010 or later[34,37,38,33,30,35,31,13].  7 
8 
Characteristics of participants. Age of participants ranged from 18 to 82 years and originated from countries such as 9 
the United States[13,18,36,32,34,35], Australia[37], Germany[31], and Spain[33,30,38] (Table 1). Participants were 10 
recruited at healthcare centers[30,35,31,32,36,37,33,38,39], workplaces[18], or used mixed recruitment strategies 11 
(e.g. workplace and online recruitment) [13]. Except for one study, which included patients with mixed symptom 12 
duration[13], remaining studies included participants with acute-subacute[37,33,30,38,32,36], or 13 
chronic[18,34,35,31] LBP symptoms only. Trials defined acute and subacute LBP as symptoms in the lower back 14 
lasting for less than eight weeks, [37] or eight to 12 weeks[32,36,38,33,30] respectively. Chronic LBP was identified 15 
by medical records[31], symptoms lasting longer than 12 weeks[34], or having at least one[18], or two[35] 16 
outpatient visits in the previous year.  17 
18 
Methodological quality. The overall quality of included studies ranged from four to eight, with the mean score being 19 
seven (0-10 PEDro score) (Table 1). The control and intervention groups did not differ at baseline in any study. Four 20 
studies (36%) had inadequate (<85%) retention of participants at follow up[18,32,36,31], and three studies (27%) 21 
did not conduct an intention-to-treat analysis[32,36,40]. The most common methodological limitation was the lack 22 
of blinding of assessor (4/11; 36%), participants (0/11; 0%), and therapist (1/11; 9%), mostly impossible in clinical 23 
studies.  24 
25 
Characteristics of telehealth-based interventions. Interventions varied in their length and components (Table 1). 26 
However, the aim of the interventions was primarily to support and educate participants in self-managing their 27 
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symptoms. Most trials included an educational component to improve the knowledge regarding LBP and to 1 
encourage an active life-style[13,18,36,32,34,33,30,38,35]. One study used a health tracker device (pedometer) to 2 
encourage physical activity [35]. Behavioral change approaches such as cognitive behavioral therapy and health 3 
coaching principles were utilized in five studies[13,36,32,34,37,35]. Trials used website[34,35,33,30,38], mobile 4 
website[13], online chat-group discussion[35,31], e-mail discussion[18], phone calls (i.e. health coaching via 5 
telephone)[36,32,37], or a combination of these telehealth strategies[35,38,33,13] to deliver interventions. 6 
Telehealth interventions were used in isolation[13,31,35,34,18], or in addition to other interventions (i.e., usual care 7 
plus web-based program)[30,33,38,37,36,32]. Intervention length ranged from four weeks[34] to one year[18,35]. 8 
Trials compared telehealth interventions to usual care[31,36,32,37,33,30,38] or minimal interventions such as non-9 
health-related[18,35] or LBP information[34,35,13].  10 
11 
Efficacy of telehealth to reduce pain. Six original trials investigated the effect of telehealth on pain 12 
reduction[13,31,35,30,33,38,34,18] (supplementary Table 1). Comparison groups consisted predominantly of 13 
minimal interventions (i.e. non-health-related or LBP information) in people with chronic LBP. Pooled analysis of 14 
four trials
18,29,32,33
 revealed a WMD for pain at short-term of -2.61 (95%CI: -5.23 to 0.01; p = 0.05; I
2
 = 0%) on a 15 
100-point scale, where negative values favor telehealth interventions. For the medium-term follow-up, two 16 
studies
29,32
 were pooled and the WMD was -0.94 (95%CI: -6.71 to 4.84; p = 0.75; I
2
 = 40%) (Figure 2). According 17 
to the GRADE classification, there is moderate quality of evidence that telehealth is not superior to minimal 18 
interventions for reducing pain in chronic LBP at the short or medium-term follow-ups (publication bias, through the 19 
inspection of a funnel plot, not investigated as fewer than ten studies were pooled[41]) (Table 2). Remaining trials 20 
that could not be pooled demonstrated that telehealth strategies, when delivered in combination with usual care, or 21 
as an unique intervention, reduced pain in patients with sub-acute symptoms,[30] and with mixed length of 22 
symptoms[13], respectively. 23 
24 
Efficacy of telehealth to reduce disability. Seven original trials investigated the effect of telehealth interventions on 25 
disability[31,35,30,33,38,37,34,36,32,18] (supplementary Table 2). For chronic LBP, four trials compared telehealth 26 
strategies mostly to minimal interventions at short-[34,35,18,31] and two at medium-term[34,31] follow-ups. Pooled 27 
analysis showed that telehealth was not superior to minimal interventions at short-term (WMD = -1.85 points; 28 
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95%CI: -4.32 to 0.62; p = 0.14; I
2
 = 0%) or medium-term follow-ups (WMD = 0.13 points; 95%CI: -4.1 to 4.4; p = 1 
0.94; I
2
 = 0%). Based on the GRADE classification, there is ‘moderate quality evidence’ that telehealth is not 2 
superior to minimal interventions for reducing disability in chronic LBP. Due to considerable heterogeneity, results 3 
for acute[32,36], and sub-acute[38,33,30,37] LBP could not be pooled. Nevertheless, findings from three individual 4 
trials indicate that telehealth combined with usual care was superior to usual care alone for reducing disability at 5 
short[33,30,38], and medium-term[32] follow-ups.  6 
7 
Efficacy of telehealth in improving physical function and quality of life. Five[36,32,37,30,35,31] and 8 
three[13,18,33,30,38] original trials investigated the effect of telehealth-based interventions on functional status and 9 
quality of life, respectively (supplementary Table 3). Meta-analysis was not feasible due to differences in LBP 10 
chronicity, outcome measurements, and follow-up length. Overall, trials reported that telehealth combined with 11 
other interventions were superior to minimal interventions in improving function for people with acute and sub-12 
acute LBP at short[37,30], and medium-term[32] follow-ups. For chronic LBP, no effect on function was found at 13 
short[35], or medium-term[31], when telehealth was used as a sole intervention and compared to minimal 14 
interventions. For improving quality of life, the three trials[13,18,33,30] reported that telehealth was superior to a 15 
control intervention regardless of duration of LBP symptoms or follow-up length. 16 
17 
Discussion  18 
Summary of findings 19 
Given the rapid advances in communication technology, telehealth has become increasingly popular for the delivery 20 
of health-related interventions for various patient groups[42]. Our results suggest that the evidence supporting the 21 
use of current telehealth-delivered interventions in the management of LBP is limited. For chronic LBP, findings 22 
from our meta-analysis provide moderate quality evidence that telehealth-based interventions are not superior to 23 
minimally-based interventions in reducing pain and disability. For acute and sub-acute LBP, a meta-analysis could 24 
not be performed. However, findings from individual studies suggest that telehealth intervention, when used as an 25 
adjunct to usual care, appear to optimize the effects of usual care in patients with recent onset of LBP symptoms. 26 
Furthermore, telehealth was superior to a control intervention for improving quality of life regardless of duration of 27 
LBP symptoms or follow-up length. Telehealth-based interventions for non-specific LBP are in their early stages of 28 
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development. Only a limited number of trials have been published, and it remains to be determined if the content of 1 
the interventions or the technology approach can explain the lack of effectiveness in chronic LBP. 2 
3 
Chronic LBP 4 
Current telehealth-based interventions (mainly based on supporting patients’ behavior change or to self-manage their 5 
condition) are not more effective than minimal interventions (i.e. health or non-health-related information) for 6 
reducing pain and disability in chronic LBP when used as a sole treatment strategy. The evaluated telehealth-based 7 
interventions demonstrated a treatment effect of less than three points on a 100-point scale. As function[35,31] and 8 
quality of life[18] were not often reported, we could not quantify the effect of telehealth-based interventions on 9 
these outcomes. Individual studies have shown no benefit in function[35,31], yet the only trial that assessed quality 10 
of life demonstrated a positive effect of telehealth at short-term follow-up[18].  11 
12 
Although limited benefit of current telehealth interventions was demonstrated for people with chronic LBP, other 13 
systematic reviews have shown favorable outcomes of telehealth-based interventions for people with cardiovascular 14 
disease, diabetes, obesity, and osteoarthritis[43-46].  The small effect identified in our review may be due to the 15 
inherent complexity of chronic LBP management and the low effectiveness of current traditional interventions for 16 
management of LBP on which telehealth strategies are built on. Another plausible reason for discrepant results may 17 
be the predominantly isolated telehealth interventions implemented for LBP management, whereas many studies of 18 
other conditions included telehealth as adjunct therapy[43-46]. 19 
20 
Poor patient compliance is often reported in internet-based trials[47]. In our review, only two studies evaluated 21 
patient adherence to the telehealth interventions, reporting that compliance was lower than recommended[18,35]. 22 
For instance, Krein et al.[35] reported that participants logged into the website only 38% of the recommended time. 23 
It is likely that poor treatment adherence may have resulted in small treatment effects associated with telehealth for 24 
LBP. Limitations in the technology used to deliver the telehealth interventions may have also contributed to the 25 
small effects found in our review. Of the four trials included in our meta-analysis, participants could not access 26 
information though their mobile devices which could have interfered with service utilization and its efficacy. For 27 
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instance, in other chronic diseases such as asthma and type 2 diabetes, the use of cell phone and text messaging 1 
showed significant improvements in intervention acceptance and compliance[42,48].  2 
3 
Another factor likely to explain the small treatment effects of telehealth for LBP is the limited efficacy of the base 4 
interventions (i.e. behavioral strategies, exercise prescription, and education) delivered through the telehealth 5 
medium. For instance, past research has shown that exercise and cognitive behavioral therapy have small effects on 6 
pain relief or function improvements (<10 points on the 100-point scale or 0.3 standard mean deviation) even when 7 
delivered face to face to patients with LBP[49-52].  Thus, it is possible that the limitations associated with telehealth 8 
are not entirely related to the medium but perhaps to the components of the intervention upon which they are based.  9 
10 
Acute and subacute LBP 11 
For acute and sub-acute LBP, we found three small trials, with less than 400 participants in total[36,30,37], where 12 
telehealth was carried out in addition to a usual care intervention (e.g.) and compared to usual care alone. Meta-13 
analysis was not feasible. The treatment effects across the trials were inconsistent. For instance, the treatment effect 14 
for disability based on standardized effect size ranged from non-significant
35
 to large
36 
at short-term follow-up. 15 
However, in at least one of the three trials, one positive finding was reported when telehealth was added to usual 16 
care for all outcomes investigated (pain[30], disability[32,30], function[32,30,37], and quality of life[30]). The 17 
variability in results may be explained by the differences in design and contents of the interventions. For instance, 18 
the trial with the largest effect size for pain and disability used the longest intervention (9 months)[38]. This is not 19 
surprising as behavior change is difficult and time consuming and may in fact be dependent on the length of the 20 
intervention.  21 
22 
Interpretation and implications for clinical practice and research  23 
Despite the spike in interest and usage of telehealth, this study highlights the limited evidence supporting the use of 24 
telehealth for non-specific LBP. To date, most telehealth-based interventions have not shown significant clinically 25 
important benefits in the outcomes investigated, in particular for chronic LBP. Future research should focus on 26 
improving the design of interventions, drawing on recent guidelines for the management of LBP, and the 27 
implementation of telehealth. As telecommunication technology improves and becomes a major source of health 28 
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information and social support [53], our findings should encourage interest in researching telehealth for non-specific 1 
LBP and its potential to enhance healthcare delivery.  2 
3 
For people with non-specific LBP, telehealth interventions have been delivered via telephone calls[32,36,37], online 4 
chat[31], websites[34,35,38,30,33], and email[18,35,38,30,33,13]. However, more recent technology such as 5 
smartphone apps, SMS, and health trackers was rarely investigated. Only one trial used a website where participants 6 
could access self-tailored strategies though their smartphones[13]. One of the major findings of our review was that 7 
those who participated in a tailored self-management web-based program based on education and behavior strategies 8 
were almost two times less likely (OR: 1.7) to experience LBP two months after the intervention compared to the 9 
control group. Benefits from mobile phone interventions have been observed in the management of chronic diseases 10 
such as diabetes, asthma, and hypertension[20,54,55]. The accessibility to smartphones and their use is increasing in 11 
both developed and developing countries [56].Therefore, studies exploring the effectiveness of telehealth-based 12 
interventions using more recent wireless mobile technology such as apps and fitness trackers are required. 13 
14 
Another area currently under-investigated is the integration of telehealth using modern communication technology 15 
with face-to-face management for LBP. The supplementation of traditional face-to-face interventions by telehealth 16 
strategies would allow multimodal interventions by combining treatments which cannot be delivered remotely (e.g. 17 
specific forms of exercises or spinal manual therapy techniques) with those which can be effectively delivered 18 
remotely such as behavioural change program[57,58]. The combination of behavioural change programs with spinal 19 
manual therapy techniques, both delivered face to face, has been shown to improve patient outcomes in chronic 20 
LBP[59,60]. Therefore, telehealth-based interventions used as an adjunct, rather than a sole intervention, could 21 
potentially optimize the effects of current treatments for LBP.  22 
23 
The profile of patients who are more likely to benefit from telehealth interventions is another area that deserves 24 
further attention. Telehealth trials included in this review reported data on recruitment sources, age, and baseline 25 
pain and disability levels – all of which affected the effectiveness of telehealth interventions[35,34]. Telehealth 26 
interventions appear to be more effective for people with acute and sub-acute LBP symptoms, although this is only a 27 
tentative finding based on the limited evidence from three small trials[36,30,37].  28 
136
Strengths and Limitations  1 
This is the first review to synthesise the findings and quantify the effectiveness of telehealth-based interventions in 2 
nonspecific LBP. We evaluated important clinical outcomes, used well-established methods to assess trial 3 
methodological quality and strength of evidence, and did not restrict our search on language. However, some 4 
weaknesses need to be acknowledged. The scope of our findings are limited due to the small number of trials and 5 
variability in the design, content, populations investigated, and measurement of outcomes. As a result, the 6 
quantitative synthesis was limited to the outcomes of pain and disability. Furthermore, due to limited research 7 
conducted in this area, we were unable to investigate factors that explain the efficacy of telehealth, such as 8 
individual patient characteristics (e.g. level of disability, patients’ personal preferences towards treatments) and 9 
intervention details (e.g. technology medium, content of intervention). As the best evidence level observed was of 10 
moderate quality, future studies with larger sample sizes may provide different estimates of the effects of telehealth 11 
for all comparisons.  12 
13 
In summary, this review provides moderate quality-evidence that telehealth-based interventions used in isolation are 14 
not more effective than minimal interventions for the reduction of pain and disability in chronic non-specific LBP. 15 
Whether the limited effectiveness is explained by the content and nature of the interventions still needs to be 16 
explored. For acute and sub-acute LBP, preliminary evidence for the potential of telehealth as an adjunct to usual 17 
care has been demonstrated in small individual trials. Larger and higher quality studies with longer follow-ups are 18 
crucial for the evaluation of the effectiveness of telehealth-based interventions. Ideally, future trials should 19 
investigate which intervention content (e.g. CBT, education, reminders about self-management), and type of 20 
telehealth delivery (e.g. SMS, apps) provides the greatest clinical improvements and which subgroup of patients 21 
would benefit most from telehealth.   22 
23 
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Figure Legends 1 
2 
Figure 1. Process for the selection of included studies. 3 
4 
Figure 2. Pooled effect of trials that investigated the effect of telehealth on pain and disability for non-specific low 5 
back.  6 
Figure 2 Footnote. CI - Confidence interval; I2 - heterogeneity of studies. Squares represent each individual study. 7 
Diamonds represent the pooled effect. Weight% represents the influence of each study in the overall meta-analysis 8 
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